NEWS
From
To
Keyword
Search
Annual screening detects breast cancers earlier for women aged 35-39 with a family history
11 February 2019
Annual screening for younger women aged 35-39 who have a family history of breast cancer would be highly effective in detecting tumours earlier, a major UK trial has found.
 
Pioneering Manchester cancer screening pilot to be rolled out nationwide
08 February 2019
Manchester’s Lung Health Check (LHC) pilot, which quadrupled lung cancer early diagnosis rates, is being extended to 10 sites across the country in a drive to save lives by catching the condition early.
 
Manchester scientist finding ways to stop breast cancer spreading
04 February 2019
Dr Ahmet Ucar has been awarded a fellowship to investigate whether targeting two key proteins can help stop breast cancer spreading.
 
Manchester researchers hope to help solve the mystery of cancers with no known origin
31 January 2019
A group has published a review of ‘cancers of unknown primary’ that explores the potential of liquid biopsy in guiding their treatment.
 
Researchers set to receive over £2 million funding from Cancer Research UK
23 January 2019
Manchester scientists are set to benefit from one of the biggest funding grants ever awarded by Cancer Research UK.
 
Researchers discover common markers of tumour hypoxia across 19 cancer types
14 January 2019
A landmark pan-cancer study involving a Manchester researcher has analysed mutation signatures of low oxygen in more than 8,000 tumours.
 
Oldham-based storytelling initiative targets local radiotherapy patients
10 January 2019
Oldham residents, who have been treated with radiotherapy for their cancer, are being invited to get involved with a new arts-based project launching in the borough this New Year.
 

2018

Manchester researchers ask the public for early detection ideas to save lives from cancer
06 December 2018
A national online survey, to gather public views about what is important in detecting cancer earlier, has been launched by scientists at the NIHR Manchester Biomedical Research Centre.
 
Roche to invest £20 million in Manchester to develop a new rare cancer research partnership
05 December 2018
Roche, one of the world’s leading biotech companies, is today announcing new investments in UK life sciences, including an innovative £20 million genomic technology partnership with The Christie in Manchester, Europe’s leading cancer centre.
 
First cancer patient in England to receive high-energy proton beam therapy set for treatment
04 December 2018
The first patient in England to receive high-energy proton beam therapy for cancer is expected to be treated later this month in Manchester.
 
digital Experimental Cancer Medicine Team win Patient Engagement award
04 December 2018
Manchester’s digital Experimental Cancer Medicine Team (digitalECMT) has received the Patient Engagement award at the Microsoft Health & Artificial Intelligence Summit held in Brussels.
 
New nano tool could pave way for better cancer testing
28 November 2018
A new tool designed by scientists at The University of Manchester has laid the foundations for in depth analysis of blood that allows the identification of previously unknown molecules in blood.
 
University cancer research facility renamed Oglesby Cancer Research Building to honour enormous contribution of Michael Oglesby
27 November 2018
The University of Manchester building for Manchester Cancer Research Centre (MCRC) researchers has been renamed in a ceremony to honour the contribution of Michael Oglesby, his family, and the Oglesby Charitable Trust to cancer research in Manchester.
 
Manchester hospitals announced as one of the first centres in the UK to offer new cutting edge cancer treatment
27 November 2018
Manchester University NHS Foundation Trust (MFT) has been named as one of a very small number of centres in the UK to offer CAR-T therapy, widely regarded as the most exciting cancer treatment development in decades.
 
University of Manchester graduate becomes Cancer Research UK's first female Chief Executive
20 November 2018
A University of Manchester graduate says she is “proud and humbled” after taking over the helm at one of the world’s foremost health charities.
 
Research leads to new way of caring for pre-cancerous condition
19 November 2018
A University of Manchester study of care provisions for patients diagnosed with Barrett’s Oesophagus, a pre-cancerous condition, has resulted in improvements in local NHS care, which may form a blueprint for other hospitals.
 
New study addresses early breast cancer detection in high risk young women
13 November 2018
A new clinical study, designed to assess whether breast density can be accurately determined in young women using low dose mammograms, is launched this month in Manchester.
 
First Manchester trial of combined imaging techniques underway with cervical cancer patients
05 November 2018
A newly launched radiotherapy study, involving cervical cancer patients, is the first in Manchester to simultaneously combine two different examinations techniques: PET-MR with tracer administration.
 
Modern radiotherapy is safe and effective in carefully selected older patients with small-cell lung cancer
31 October 2018
Researchers in Manchester have looked at the outcomes of older patients in a lung cancer radiotherapy trial, compared to those of younger patients.
 
Registration open for Manchester Phase I conference
30 October 2018
We are delighted to announce that registration for the MCRC/ECMC ‘Phase I: where science becomes medicine’ conference is now open.
 
Drugs’ side effects in lungs ‘more widespread than thought’
29 October 2018
A systematic review of research has revealed that the toxic effects on the lung of drugs commonly taken to treat cancer is much more widespread than thought.
 
Professor Andrew Renehan receives Sir Edward Hughes Oration award
27 October 2018
Professor Andrew Renehan has received the Sir Edward Hughes Oration award at the Spring Colorectal Meeting of the Colorectal Surgical Society of Australia and New Zealand and the Colon & Rectal Surgery Section, Royal Australasian College of Surgeons.
 
Weight loss surgery for obese women prevents womb cancer
26 October 2018
Doctors have long known that womb cancer is caused by obesity, however, until now, the effect of losing weight on precancerous changes in the womb have been poorly studied.
 
Deep learning powered metastases detection system for digital pathology
24 October 2018
In a collaboration with the med tech company DeepMed.IO Ltd, key MCRC members have been instrumental in supporting a successful application to a SBRI Healthcare call earlier this year.
 
Cancer trial shows treating the prostate with radiotherapy improves survival
21 October 2018
Treating the prostate with radiotherapy alongside standard treatment led to a 32% increase in survival for some men with metastatic prostate cancer, who have a low burden of disease.
 
The Christie is the first specialist hospital to be rated Outstanding twice
12 October 2018
The Christie NHS Foundation Trust has once again been rated Outstanding by the health regulator becoming the first specialist trust in the country to be given their highest accolade twice.
 
Proton Beam Therapy Centre wins Building of the Year
05 October 2018
Greater Manchester Chamber of Commerce has named The Christie Proton Beam Therapy Centre as the winner of its Building of the Year Award.
 
Manchester-led study finds people with type 2 diabetes at higher risk of death from both obesity-related and non-obesity related cancers
03 October 2018
Being overweight or obese may put adults with diabetes at greater risk of dying from cancer than their diabetes-free counterparts, according to new research.
 
Innovative paediatric CAR-T therapy study meets recruitment target
17 September 2018
The paediatric oncology research team at Manchester University NHS Foundation Trust and colleagues in London have met their recruitment target for an innovative CAR-T therapy study.
 
Manchester cancer scientists explore cells within cells
13 September 2018
A team involving researchers from the Cancer Research UK Manchester Institute has shown that a mutant gene is linked to the formation of cell-in-cell structures.
 
NHS staff are Pride of Manchester
07 September 2018
NHS staff from across Greater Manchester won ‘Best Overall Entry’ at the 2018 Manchester Pride Parade.
 
Carers of terminally ill up to seven- times more likely to have mental health problems
24 August 2018
Carers for people with cancer are between 5 and 7 times more likely to have mental health problems than the general population, according to a landmark new study.
 
Cancer biotechnology project wins Eli and Brit Harari Graphene Enterprise Award
23 August 2018
The new technology business will share this year’s £70,000 prize for novel applications of graphene.
 
Dermatologists show the benefit/risk of sunlight exposure is linked to skin colour
10 August 2018
For the first time researchers have shown the differing relationship between benefit and risk of sunlight (UVR) exposure for people of different skin types.
 
Honorary Chair for Consultant Gastroenterologist
08 August 2018
Consultant Gastroenterologist Yeng Ang from Salford Royal NHS Foundation Trust has been awarded an Honorary Chair by The University of Manchester, to mark the academic and research progress he is leading.
 
Spatio-temporal regulation of key Rho-family protein is linked to perinuclear actin cap function
08 August 2018
A study provides new insight into the regularity mechanisms behind the perinuclear actin cap, a key regulator of nuclear morphology.
 
Researchers identify a novel type of genetic change resulting in inherited breast cancer
03 August 2018
Researchers in Manchester have identified a new mechanism which switches off a gene in families affected by breast and ovarian cancer.
 
Rise in number of Christie research trials
01 August 2018
The number of clinical trials that are recruiting patients at The Christie has jumped by 11 per cent in the last year.
 
Manchester cancer researchers help create a buzz for city-wide sculpture trail
24 July 2018
Cancer scientists feature on one of 80 giant bee sculptures on display in Manchester city centre to celebrate the city’s pioneering spirit.
 
New world-leading precision medicine campus set to open in Manchester
11 July 2018
Proposals have been announced to create a world-leading precision medicine campus in the Corridor Manchester Enterprise Zone, located on the UK’s largest clinical academic campus.
 
Honorary appointment for outgoing CEO of cancer charity
06 July 2018
Sir Harpal Kumar, the eminent and influential Chief Executive of Cancer Research UK, has been appointed an honorary Chair in Cancer Sciences at The University of Manchester.
 
Institute scientist is Acteria Prize winner
05 July 2018
Eduardo Bonavita, a Postdoctoral Fellow at the Cancer Research UK Manchester Institute, has won the Acteria Prize for the best PhD thesis in Immunology in Europe.
 
First of its kind pancreatic cancer trial begins in Manchester
04 July 2018
A ground-breaking new pancreatic cancer trial, which aims to match patients with more targeted and effective treatments for their tumours has now opened in Manchester.
 
Paterson fire recovery team recognised at University’s Distinguished Achievements Awards
02 July 2018
The cross-disciplinary team was recognised alongside those of staff and students at the ceremony that took place at the end of June at The University of Manchester.
 
Prestigious award for urological cancer surgeon
27 June 2018
Professor Noel Clarke has been awarded the prestigious St Peter’s Medal by the British Association of Urological Surgeons.
 
New Lydia Becker Institute of Immunology and Inflammation
22 June 2018
The University of Manchester Research Institute has approved the establishment of a new Institute to be based in the Faculty of Biology, Medicine and Health that will undertake research into the immune system.
 
Professor van Herk wins Innovation Impact Award
19 June 2018
Professor Marcel van Herk has been presented with an Innovation Impact Award from Amsterdam University for his ground breaking work on image guided radiation therapy.
 
Cancer research to benefit from University’s Investing in Success
14 June 2018
Two projects – visits for lung cancer research and a trip for Team Science insight – gained funding from a prestigious University scheme.
 
Research staff honoured at Christie annual awards
12 June 2018
Research staff at The Christie NHS Foundation Trust in Manchester have been recognised for their exceptional work at the specialist cancer centre’s annual staff awards.
 
Institute scientist wins BACR prize
11 June 2018
Zoi Diamantopoulou, a postdoctoral fellow at the Cancer Research UK Manchester Institute, was recently awarded the prestigious BACR Chris Marshall Prize for Cell Signalling.
 
Manchester trio honoured by royal college
25 May 2018
Three cancer researchers from Manchester have been recognised in a ceremony at The Royal College of Radiologists in London.
 
Bladder cancer charity funds Manchester study
25 May 2018
Action Bladder Cancer UK has funded a project to explore personalising treatment of bladder cancer using genomic and radiomic data.
 
Cancer research arrives at the Platform for Investigation
23 May 2018
Nearly 40 researchers from across the MCRC partnership took part in a weekend public engagement event at the Museum of Science and Industry.
 
Researchers re-assess follow up in bowel cancer patients
22 May 2018
A study involving Manchester medics has found that bowel cancer patients could safely have fewer follow-up CT scans.
 
Manchester welcomes eminent academic clinical oncologist
18 May 2018
Professor Peter Hoskin has been appointed as Chair in Clinical Oncology at The University of Manchester.
 
CRUK Manchester Institute researcher receives a Fulbright Award to the US
16 May 2018
Dr Stuart Williamson, a postdoctoral researcher from the CRUK Manchester Institute has received a Fulbright-Cancer Research UK Scholar Award to enable him to research at Stanford University on one of the most well-regarded and impactful scholarship programmes in the world.
 
Study paves the way for better treatment of prostate cancer
11 May 2018
A new study has found a way to identify men with locally advanced prostate cancer who are less likely to respond well to radiotherapy.
 
Cancer expert elected Fellow of the Royal Society
10 May 2018
The Royal Society has granted its prestigious fellowship to Professor Richard Marais, Director of the Cancer Research UK Manchester Institute.
 
Manchester charity award grant extension to research bone cancer in children
03 May 2018
Manchester children’s cancer research charity, Friends of Rosie, announce a further grant award of £65,000 to fund a second year of research into the treatment and improved detection of rare bone cancer in children.
 
Technology used to map Mars now measuring effect of treatment on tumours
24 April 2018
A machine learning approach for assessing images of the craters and dunes of Mars, which was developed at The University of Manchester, has now been adapted to help scientists measure the effects of treatments on tumours.
 
Truncation- and motif-based pan-cancer analysis reveals tumour-suppressing kinases
17 April 2018
Scientists at the Cancer Research UK Manchester Institute have developed a bioinformatics pipeline that has identified novel kinases involved in tumour growth in stomach cancers.
 
New project in Manchester to explore similarity between pancreatic and breast cancer
12 April 2018
Pancreatic Cancer Research Fund (PCRF) has awarded a £85k grant to Dr Mairéad McNamara to probe the genetics of advanced pancreatic adenocarcinoma.
 
New world-class cancer centre to open in Manchester
11 April 2018
An ambitious, world-class cancer research facility is to be built at The Christie on the site of the Paterson building which suffered devastating fire damage in April 2017 displacing over 300 scientists and support staff.
 
World renowned cancer researcher comes to Manchester
23 March 2018
One of the world’s leading experts in genitourinary oncology is to join The University of Manchester and The Christie NHS Foundation Trust.
 
Top healthcare science award for Christie expert
13 March 2018
A leading physicist at The Christie has been named Healthcare Scientist of the Year at the prestigious Healthcare Science Awards.
 
IDEAYA Biosciences and Cancer Research UK announce partnership agreement to develop small molecule inhibitors of PARG
13 March 2018
The oncology-focused biotechnology company has entered into a partnership with Cancer Research UK’s (CRUK) Commercial Partnerships Team and the Drug Discovery Unit at the Cancer Research UK Manchester Institute.
 
Multi-million pound government award to Manchester health consortium
12 March 2018
A recently formed Manchester health consortium, led by The Christie, has been awarded nearly £7 million of funding to ensure more patients benefit from a new generation of disease-fighting drugs for cancer.
 
North West children’s charity grant a further £66,500 following promising childhood brain tumour study
26 February 2018
Friends of Rosie reports encouraging results from a research project investigating the use of immunotherapy to treat childhood brain tumours that are resistant to conventional treatment methods.
 
Institute researcher awarded Kay Kendall Leukaemia Fund Junior Research Fellowship
12 February 2018
Dr Isabel Romero-Camarero, from the Cancer Research UK Manchester Institute, has been awarded a prestigious Kay Kendall Leukaemia Fund (KKLF) Junior Research Fellowship.
 
MCRC Director gives keynote lecture at ASCO symposium
10 February 2018
Professor Rob Bristow, Director of the Manchester Cancer Research Centre, has addressed the 2018 Genitourinary Cancers Symposium in San Francisco this month.
 
Cancer medic receives prestigious faculty award
08 February 2018
Dr Rob Metcalf has been awarded The Dean’s Prize from The University of Manchester.
 
Radiotherapy expert moves to Manchester
01 February 2018
Professor Neil Burnet has been appointed as Chair in Clinical Academic Proton Therapy at The University of Manchester.
 
Institute researcher invited to give prestigious conference lecture
30 January 2018
Dr Amaya Virós from the Cancer Research UK Manchester Institute has been chosen to deliver the Rising Star Lecture as the representative of the European Society for Dermatological Research (ESDR) at the 2018 International Investigative Dermatology Meeting.
 
Genetic test could give women a more accurate breast cancer risk when combined with standard screening
25 January 2018
New research shows a promising genetic test, when combined with mammograms, could provide a more accurate breast cancer risk in women attending routine breast cancer screening.
 
Top 50 healthcare innovator appointed as Health Innovation Manchester’s Chief Executive Officer
19 January 2018
Professor Ben Bridgewater, a digital trailblazer in healthcare and former cardiac surgeon, who was named as one of the UK’s top 50 health innovators, has been appointed as Health Innovation Manchester’s new Chief Executive Officer.
 
Professor Caroline Dive awarded CBE in the New Year's Honours list
01 January 2018
In this year’s New Year’s Honours list, Deputy Director of the Cancer Research UK Manchester Institute Professor Caroline Dive has been named a Commander of the Order of the British Empire (CBE) for her services to cancer research.
 

2017

Manchester scientist advises on Corrie cancer storyline
20 December 2017
Dr Ayse Latif from The University of Manchester responded to a request from Coronation Street to ensure that their recent testicular cancer storyline was accurate.
 
PhD student wins ESTRO best abstract prize
19 December 2017
Corinne Johnson, a medical physicist from The Christie NHS Foundation Trust, has been awarded the Donal Hollywood prize for best abstract at ESTRO 2018.
 
Society for Melanoma Research chooses Manchester for 2018 Congress
17 December 2017
The Society for Melanoma Research (SMR) has announced that their 15th International Congress will be held in Manchester in 2018.
 
Manchester researchers awarded MRC grant to study ovarian cancer
12 December 2017
Dr Pat Caswell and co-investigators Prof Richard Edmondson and Dr Emma Crosbie from The University of Manchester have received £550,000 from the Medical Research Council for a 3-year project to better understand the biology behind the spread of ovarian cancer.
 
World first clinical trial at The Christie will be Anna’s 10th roll of the dice in cancer battle
11 December 2017
A breast cancer patient from Rochdale, who has already tried nine different treatments, has become the first in the world to be given an exciting new combination of cancer busting drugs.
 
Institute 3Rs star wins the 2018 Andrew Blake Tribute Award
11 December 2017
Senior Scientific Officer Melanie Galvin from the Cancer Research UK Manchester Institute is to be honoured with the Andrew Blake Tribute Award for 2018.
 
Blood test could help predict skin cancer’s return
06 December 2017
Scientists in Manchester have discovered that testing skin cancer patients’ blood for tumour DNA could help predict the chances of an aggressive cancer returning.
 
Institute welcomes two new fellows
05 December 2017
Dr Maximiliano Portal and Patricia Muller have been appointed as new Institute Fellows at the Cancer Research UK Manchester Institute.
 
Manchester team visit Glasgow for fire recovery insight
29 November 2017
Members of Manchester’s cancer research leadership team have taken a tour of the Glasgow School of Art’s Mackintosh building to learn about their recovery from a devastating fire in 2014.
 
University Medal of Honour for Professor Nic Jones
28 November 2017
University presents world-leading cancer researcher with its highest medal
 
Institute Group Leader to receive €2million ERC funding
28 November 2017
The European Research Council has today announced the names from across Europe that have been awarded the Consolidator Grant
 
Cancer Research UK Manchester Institute to set up major base at Alderley Park
24 November 2017
The Institute is taking circa 81,000 sq ft of laboratory and office space in an agreement that will see over 300 scientists conduct research and development activity from a site that already has an international reputation for breakthroughs in oncology.
 
Nanobots pass first stage in ‘fantastic voyage’ from fiction to fact
23 November 2017
A team of scientists has created a new generation of tiny remote controlled nanorobots which could one day allow doctors to deliver cancer drugs from within the human body.
 
Success for The Christie in regional clinical research awards
14 November 2017
Three high-flying Christie employees were awarded winners’ trophies at the Greater Manchester Clinical Research Awards last week.
 
Manchester researcher recognised with Royal College prize
08 November 2017
Dr Lingjian Yang from The University of Manchester has been named by the Royal College of Radiologists as a winner of the 2017 Ross Award.
 
Institute scientist named as ‘Future Leader’ by Cancer Research UK
06 November 2017
Dr Santiago Zelenay from the CRUK Manchester Institute has received Cancer Research UK’s Future Leader Prize at the NCRI Cancer Conference in Liverpool this week.
 
Researchers from Manchester win prize as part of national team
06 November 2017
Professors Caroline Dive and Fiona Blackhall have been named as part of the team to win Cancer Research UK’s Translational Cancer Research Prize for 2017.
 
Classical musician alive thanks to Christie drugs trial
25 October 2017
Classical musician given months to live is alive four years later thanks to Christie cancer drugs trial
 
SMR Outstanding Research Award for Institute leader
21 October 2017
At this year’s Society for Melanoma Research Congress, held in Brisbane Australia, Professor Richard Marais was presented with the Outstanding Research Award
 
Strategic partnership doubles cancer trials available to Manchester patients
19 October 2017
In April, Manchester patients had access to twice as many cancer trials, as a result of a new strategic partnership across five CRUK Experimental Cancer Medicine Centres (ECMCs).  
 
Second phase of trial to match patients to the right cancer treatment now open
19 October 2017
Researchers across Manchester have pulled together to open phase two of the TARGET cancer trial, which is on track to recruit over 100 patients in its first year. 
 
Manchester researchers publish research into the use of new MR-linac technology
17 October 2017
Two papers recently published by Manchester researchers will help shape guidance for targeting tumours more accurately using the new MR-Linac, which combines MRI scanning and radiotherapy in one hi-tech package.
 
Manchester scientist to investigate how to stop breast cancer spreading to the bone
13 October 2017
University of Manchester scientist awarded major funding as Breast Cancer Now announces four new projects tackling metastatic breast cancer
 
Garden rose scanned to test revolutionary new MR-linac
13 October 2017
A red rose, picked from the garden at The Christie by a patient, has been chosen as the first item to be scanned by the hospital’s revolutionary new MR-linac radiotherapy machine.
 
The Christie highlighted as a leading example within the NHS
12 October 2017
The Christie NHS Foundation Trust has been held up by the independent health regulator the Care Quality Commission (CQC) as a positive example within the National Health Service.
 
New test set to transform breast cancer prevention
09 October 2017
Women who have a family history of breast cancer are set to benefit from a new genetic test that assesses breast cancer risk, with plans for it to enter clinical practice within the next six months.
 
Paediatric oncology research team recruit first patient in UK to worldwide cancer study
28 September 2017
SPARKLE is a global research study for children and young adults with Mature B cell non-Hodgkin Lymphoma where standard treatment has not worked or if their cancer has returned after chemotherapy.
 
Lung cancer treatment could be having negative health effect on hearts
25 September 2017
Radiotherapy treatment for lung cancer could have a negative effect on the health of your heart new research has found.
 
DDU make progress on new leukaemia drugs
12 September 2017
Scientists from the Cancer Research UK Manchester Institute have refined the structure of several series of chemical compounds with the potential to treat multiple cancer types.
 
Scientists take step forward in understanding of oesophageal cancer
01 September 2017
Scientists at The University of Manchester have identified some key factors that establish oesophageal cancer cells.
 
Tech tool to help fight against cancer
25 August 2017
A tech research tool which could help in the fight against cancer has been licensed to Arriani Pharmaceuticals by the University technology transfer company UMI3 Ltd for €1.3million.
 
Generous fellowships for research into rare blood cancer
23 August 2017
The Oglesby Charitable Trust is funding a research team to investigate an unusual type of chronic leukaemia.
 
Major breakthrough in the treatment of anal cancer
16 August 2017
Specialists at The Christie and The University of Manchester have made a breakthrough which could potentially improve detection and treatment of anal cancer, as well as have wider implications for other cancers.
 
Manchester researchers uncover novel insights into early detection of cancer
15 August 2017
Three new publications provide information that could shape the way in which patients with a genetic predisposition are screened for cancers.
 
More patients than ever gain access to clinical trials at The Christie
03 August 2017
The number of patients benefiting from clinical research trials at The Christie has almost doubled in the past year.
 
Gene signature could help personalise radiotherapy in bladder cancer
25 July 2017
Scientists from The University of Manchester have pinpointed a gene signature that identifies which bladder cancer patients would benefit from more aggressive treatment.
 
MCRC building hosts inaugural lectures for new University professors
19 July 2017
Two Manchester professors working in cancer research have given their inaugural lectures as part of a ceremony held at the MCRC building.
 
Manchester scientist to study how ‘hibernating’ breast cancer cells evade treatment
12 July 2017
A leading Manchester scientist has been awarded a grant worth over £185,000 by Breast Cancer Now to investigate how breast cancer cells are able to hibernate for years before returning elsewhere in the body.
 
Advanced radiotherapy improves lung cancer survival rates
04 July 2017
A 10-year University of Manchester and Christie NHS Foundation Trust study which used advanced radiotherapy techniques in patients with limited-stage small cell lung cancer (SCLC) has achieved the best survival rates and lowest toxicity ever reported.
 
Experimental drug trial provides lifeline for cancer patient
03 July 2017
A patient with a fast-growing lymphatic cancer, who had failed to adequately respond to previous cancer treatments, has had a dramatic response to a brand new drug.
 
Expert in cancer therapeutics to lead Drug Discovery Unit
23 June 2017
One of the leading experts in cancer therapeutics will be joining the Cancer Research UK Manchester Institute to lead its Drug Discovery Unit.
 
Cyclotron arrives at The Christie
23 June 2017
A key component of the proton beam therapy machine, the cyclotron, has been installed at The Christie, marking a major milestone in a national NHS plan to provide high energy proton beam therapy in the UK from 2018. 
 
New insight into reining in bowel cancer spread
22 June 2017
Manchester scientists have uncovered a two-pronged defence against aggressive bowel cancer.
 
Symposium brings together world-wide radiotherapy community
20 June 2017
A conference in Manchester covering research into all aspects of radiotherapy has been hailed as a great success.
 
The Christie is top UK recruiting centre for four studies
15 June 2017
The Christie NHS Foundation Trust is the highest UK recruiting centre for a number of studies thanks to a research team’s excellent work.
 
Leaders come together for joint launch event
15 June 2017
The NIHR Manchester Biomedical Research Centre (BRC) and Clinical Research Facility (CRF) launch event on 6 June 2017 represented a double celebration.
 
MCRC Director delivers inaugural lecture for new education and research partnership
08 June 2017
Professor Nic Jones spoke at the launch of RCPE Manchester, a new collaboration between Manchester Academic Science Centre (MAHSC) and the prestigious Royal College of Physicians of Edinburgh (RCPE).
 
Tumour ecosystem greater than the sum of its parts
07 June 2017
Manchester scientists have shown how normal cells that surround a melanoma tumour are affected by it, making cancer more resistant to drug treatment.
 
Richard helps raise ovarian cancer awareness
06 June 2017
Richard Edmondson, Clinical Professor in Gynaecological Oncology based in the Division of Cancer Sciences, has teamed up with the father of a former patient to raise money and awareness for ovarian cancer research.
 
World leading clinician-scientist to head cancer research in Manchester
22 May 2017
One of the world’s leading prostate cancer experts has been appointed by The University of Manchester to lead its cancer research strategy and to be the new Director of the Manchester Cancer Research Centre (MCRC).
 
New antibody drug-conjugate could be used to target treatment-resistant childhood leukaemia
17 May 2017
Researchers at The University of Manchester have discovered that a protein (5T4) found on the surface of cells contributes to chemotherapy resistance in the most common type of childhood leukaemia. Using a novel approach, early testing shows that targeting the protein with an antibody drug conjugate (ADC) could hold promise in improving treatment.
 
Major European Commission grant to boost Manchester researchers’ quest for scanning techniques to improve arthritis and cancer drug safety
18 April 2017
The University of Manchester is part of a new consortium which will develop new CT and MRI scan techniques and biomarkers to look at the accumulation of compounds in the body caused by drugs and the harm they may cause – potentially improving patients’ safety and the development of new treatments.
 
Cancer is complex, but so are our sexualities: LGB people with cancer share video experiences of care
18 April 2017
The unique experiences of lesbian, gay, bisexual and queer people with cancer have been shared on a new video hub from The University of Manchester, funded by Macmillan Cancer Support – highlighting differences in their care, and issues around sex, support and bereavement.
 
Scientists identify new way of attacking breast cancer
18 April 2017
Scientists have discovered a brand new way of attacking breast cancer that could lead to a new generation of drugs.
 
Manchester scientists to receive £1.2million for new era in pancreatic cancer research
24 March 2017
Manchester scientists are set to receive £1.2million from Cancer Research UK to help transform pancreatic cancer treatment in the UK.
 
Manchester scientist receives one of Europe’s most prestigious awards for cancer research
20 March 2017
Professor Richard Marais, Director of the Cancer Research UK Manchester Institute, has been awarded the Léopold Griffuel Award in Translational and Clinical Research.
 
Lung cancer early diagnosis rates soar during UK-first CT community scanner pilot
15 March 2017
Lung cancer early diagnosis rates have soared during a targeted screening pilot in Manchester where on-the-spot CT scans were offered in shopping area car parks.
 
Cancer PED poster recognised at national conference
13 March 2017
Manchester researchers achieved peer recognition for their approach to cancer prevention and early diagnosis (PED), at a recent Cancer Research UK conference.
 
Manchester cancer scientist takes her research to Parliament
10 March 2017
Dr Becky Ann Selina Bibby, 26, a research associate at The University of Manchester is attending Parliament to present her bioscience research to a range of politicians and a panel of expert judges, as part of STEM for BRITAIN on Monday 13 March.
 
The Christie rated top specialist hospital in the country
02 March 2017
Manchester’s cancer hospital The Christie NHS Foundation Trust has been revealed to be the top specialist trust in England and one of the best three trusts overall.
 
Hitgen and Cancer Research UK’s Manchester Institute enter licence agreement in lung cancer
28 February 2017
Cancer Research UK, Cancer Research Technology (CRT), and HitGen Ltd announced today that they have entered into a licence agreement to develop a novel class of drugs against lung cancer.
 
Friends of Rosie fund new £68,000 grant researching bone cancer in children
15 February 2017
The one-year grant of £68,000 will fund a new project to research the treatment and improved detection of osteosarcoma – a rare type of bone cancer that most commonly affects children and young people.
 
Yorkshire Cancer Research funds cross-pennine partnership
06 February 2017
Researchers at The Christie NHS Foundation Trust will join forces with Leeds Teaching Hospitals NHS Trust to improve radiotherapy treatment for patients with lung cancer.
 
World first drug trial at The Christie makes Bob's cancer disappear
03 February 2017
A patient, whose cancer spread from his lungs to his lymph nodes has been left with no trace of the disease after taking part in a first in world drug trial at The Christie in Manchester.
 
Inbuilt body clocks link breast stiffness to cancer risks
31 January 2017
University of Manchester biologists have discovered that breast tissues have 24-hour body clocks, and that several hundred genes are regulated in a daily cycle.
 
University marks World Cancer Day
31 January 2017
World Cancer Day on February 4 is a chance for us all to explore what everyone – as a collective or as individuals – can do their part to reduce the global burden of cancer.
 
Oncology nurses learn impact of clinical research during successful study day
31 January 2017
In January, Central Manchester University Hospitals NHS Foundation Trust hosted its quarterly chemotherapy study day for experienced nurses who are learning to administer chemotherapy based in the community and oncology wards.
 
Oldham scientist backs World Cancer Day
30 January 2017
An Oldham scientist, who is playing an important role in developing the cancer drugs of the future to improve treatment for patients, is urging people to support World Cancer Day on Saturday 4 February.
 
Research agreement could prevent cervical cancer in millions of women
30 January 2017
The University of Manchester, through its Innovation Company (UMI3), has signed a licensing and research agreement with Douglas Pharmaceuticals that could save the lives of millions of women around the world suffering from early stage cervical cancer.
 
New drug cocktail unlocks potential of new Leukaemia treatment
23 January 2017
A new combination of drugs, tested by University of Manchester scientists, has significantly enhanced the survival of laboratory mice with lymphoma.
 
The CRT Pioneer Fund and Cancer Research UK's Manchester Institute nominate cancer drug candidate
20 January 2017
The Cancer Research Technology Pioneer Fund LP (CPF) today (Friday) has announced it will further develop a promising class of cancer drugs called RET inhibitors, through a collaboration with the Cancer Research UK Manchester Institute Drug Discovery Unit, at The University of Manchester.
 
100,000 Genomes Project needs cancer and rare diseases patients
20 January 2017
Patients with cancer and rare diseases in Greater Manchester are being encouraged to participate in a transformative, national health initiative, the 100,000 Genomes Project.
 
Check out our fight against cancer
17 January 2017
The University of Manchester will be marking World Cancer Day by highlighting the world-class, interdisciplinary cancer research that sets it apart from other research-intensive institutions.
 
Recognition for Manchester young investigator
16 January 2017
Dr Louise Carter, a senior clinical fellow at The Christie, has received a European CanCer Organisation (ECCO) award for researcher development.
 

2016

Manchester hosts launch of Proton Therapy Network
16 December 2016
The first of a series of launch events for the EPSRC Grand Challenge Network+ in Proton Therapy took place in Manchester this week.
 
Manchester set to get around £42 million boost for cancer research
15 December 2016
Manchester is set to receive a major cash injection from Cancer Research UK. The charity plans to invest around £39 million over the next five years into the Cancer Research UK Manchester Centre*, a partnership between Cancer Research UK, The University of Manchester and the Christie NHS Foundation Trust.
 
Double win for Manchester in Understanding Animal Research's Openness Awards
10 December 2016
The University of Manchester has won two awards for the way in which it communicates animal research.
 
Major investment planned for Manchester’s Cell-Matrix Research Centre
07 December 2016
The Wellcome Centre for Cell-Matrix Research at The University of Manchester will receive a major funding boost as part of an £118m injection announced today by charitable foundation, Wellcome Trust.
 
£226 million UK investment in cancer research announced
01 December 2016
Manchester is set to benefit from Cancer Research UK investment across 13 Cancer Centres and 18 ECMCs.
 
Successful clinical pharmacology training scheme renewed
23 November 2016
A highly successful University scheme to train “high flyers” who are likely to become future leaders in academia and industry has been renewed by the Medical Research Council (MRC).
 
Multi-disciplinary workshops to tackle complexities of cancer prevention and early detection
22 November 2016
Cancer themed problem solving workshops, aimed at researchers and health care professionals, are the next stage of a Greater Manchester cancer prevention and early detection (PED) initiative.
 
Blood test could predict best treatment for lung cancer
21 November 2016
A blood test could predict how well small-cell lung cancer (SCLC) patients will respond to treatment, according to new research.
 
Specialist cancer hospital The Christie rated Outstanding
18 November 2016
Manchester's specialist cancer hospital The Christie NHS Foundation Trust has been rated outstanding by the health watchdog who called it ‘exceptional’ and ‘a leader in its field’.
 
Government invests a further £12.5m in Greater Manchester’s devolved health system to expand pioneering clinical research
18 November 2016
In a second boost for Manchester in as many months, a single city-wide bid has been awarded £12.5m by the Department of Health to fund the cutting-edge research space, highly trained staff and specialist equipment required to develop and deliver pioneering new treatments across three NHS sites in Greater Manchester.
 
Pseudo-blood vessels linked to poor survival in lung cancer
11 November 2016
The Clinical and Experimental Pharmacology group from the Cancer Research UK Manchester Institute has worked with scientists in the US to explore vasculogenic mimicry (VM) – where tumour cells form themselves into blood vessels – in small cell lung cancer (SCLC).
 
Adult weight gain could increase cancer risk
07 November 2016
Substantial weight gain over many years increases the risk of obesity-related cancers in men by 50 per cent and in women by almost 20 per cent, according to new research.
 
Centre researchers show that science is spectacular at Manchester Museum
28 October 2016
Jaw-dropping and hair-raising science experiments will be the order of the day during the latest Spectacular Science takeover of Manchester Museum.
 
Magnet delivered for revolutionary radiotherapy machine
12 October 2016
Work has started on building a pioneering radiotherapy machine at The Christie that can ‘see and treat’ cancer with pinpoint accuracy.
 
Roadmap to get new cancer scans into clinic
11 October 2016
A team of international scientists has outlined key recommendations for a global standard for scanning biomarkers in cancer - to bridge the gap between research and the clinic, according to a new paper published in Nature Reviews Clinical Oncology.
 
CRT and University of Manchester receive success payment from GlaxoSmithKline for cancer epigenetics research collaboration
06 October 2016
Cancer Research Technology (CRT) – the development and commercialisation arm of Cancer Research UK – has today received a success payment from GlaxoSmithKline resulting from its collaboration developing molecules targeting cancer epigenetics.
 
New method to detect ageing cells – and aid rejuvenation therapies - developed by researchers
04 October 2016
Scientists have discovered a new way to look for ageing cells across a wide range of biological materials; the new method will boost understanding of cellular development and ageing as well as the causes of diverse diseases.
 
Major award for graphene and 2D materials in biomedicine
29 September 2016
The University of Manchester has been awarded more than £5m for research into using nanomaterials including graphene in the human body.
 
Cancer prevention and early detection boosted by launch of a new research programme
28 September 2016
The NHS could save £44 million a year in treatment costs if four cancers were diagnosed more quickly, according to cancer experts at the launch of a dedicated prevention and early detection (PED) research initiative in Manchester.
 
Christie consultants made professors
27 September 2016
Three consultants from The Christie NHS Foundation Trust, one of Europe's leading cancer centres, have been made professors.
 
State of the art Cyclotron for The Christie
22 September 2016
One of the most advanced pieces of equipment for the UK’s first NHS high energy proton beam therapy (PBT) centre has been built for The Christie in Manchester, and will be installed in June 2017.
 
Landmark award for Greater Manchester’s devolved health system – £28.5m invested to pioneer lifesaving research and new treatments
14 September 2016
Today history has been made as a single Manchester bid has been awarded £28.5m from the NIHR, bringing lifesaving tests and treatments a step nearer for millions of people.
 
Scientist’s dedication to charity earns national praise
13 September 2016
A Manchester scientist has received a national award from Cancer Research UK in recognition of his outstanding contribution to the cause.
 
Lung cancer patients whose tumour has spread to the brain could be spared radiotherapy
04 September 2016
Patients with non-small cell lung cancer which has spread to the brain could be spared whole brain radiotherapy as it makes little or no difference to how long they survive and their quality of life according to a clinical trial involving Manchester doctors and patients.
 
Fishing for clues into unusual form of melanoma
31 August 2016
Scientists in Manchester have developed a fish-based laboratory model to better understand the genetic faults that lead to melanoma of the eye.
 
Leukaemia blood testing has 'massive potential'
17 August 2016
Researchers at The University of Manchester have unlocked the potential of a new test which could revolutionise the way doctors diagnose and monitor a common childhood Leukaemia.
 
Cellular signalling 'tug-of-war' proteins identified
16 August 2016
Manchester scientists have explained some of the contradictory behaviour of a molecule known as Rac1 by showing that its activity depends on where its 'push' comes from.
 
Funding boost for pancreatic cancer research
16 August 2016
Dr Claus Jorgensen, who leads the Systems Oncology group at the Cancer Research UK Manchester Institute, has recently been awarded further funding from the Rosetrees Trust.
 
Fabrics inspired by cancer research go on display in Manchester
04 August 2016
Cancer patients, scientists and fashion designers have worked together to create an intriguing exhibition with a difference, which has been on display in Manchester as part of European City of Science.
 
Manchester scientists get £1.47million funding boost for lung cancer research
04 August 2016
The University of Manchester is to lead a £1.47million Cancer Research UK programme to bring major advances in lung cancer treatments – the North West’s most common cancer.
 
Twin blood cell growth proteins are not identical
01 August 2016
Researchers in Manchester have shown that a pair of proteins involved in the development of blood cells may have different roles to play, with one apparently much more implicated in certain types of leukaemia.
 
Manchester to host prestigious conference
27 July 2016
The Christie NHS Foundation Trust and University College London Hospitals NHS Foundation Trust (UCLH) together with Marketing Manchester, are delighted to be awarded the opportunity to host to prestigious Particle Therapy Co-Operative Group Annual Congress (PTCOG) in 2019, in Manchester.
 
Markers that cause toxic radiotherapy side-effects in prostate cancer identified
26 July 2016
A new study involving researchers from The University of Manchester looked at the genetic information of more than 1,500 prostate cancer patients and identified two variants linked to increased risk of radiotherapy side-effects.
 
Dr Emma Crosbie's Womb Cancer Alliance video highly commended in NIHR New Media Competition
19 July 2016
Dr Emma Crosbie, Senior Lecturer, The University of Manchester and Honorary Consultant in Gynaecological Oncology, Saint Mary’s Hospital was recently highly commended in round six of the NIHR New Media Competition for her video on the Womb Cancer Alliance.
 
Manchester cancer scientists among those to get on their soapboxes
14 July 2016
Soapbox Science is back in Manchester and cancer researchers from the Cancer Research UK Manchester Institute are taking part.
 
New European Consortium launched to fight eye cancer
13 July 2016
The Cancer Research UK Manchester Institute will be a partner in a new European Consortium to foster research on metastatic uveal melanoma and identify new treatments for this serious disease.
 
Good indicator of cancer prognosis turned on its head by new research
07 July 2016
A molecule which, for the last 20 years has been believed to be an indicator of good prognosis in tumours has been shown to have a dark side by new research from The Universities of Manchester, Athens and collaborators, recently published in Nature Cell Biology.
 
European cancer scientists converge on Manchester to share latest research
05 July 2016
Cancer experts from around Europe will converge on Manchester this weekend (July 9-12) to share expertise with the city's world-leading scientists at a special Congress.
 
UHSM is top performer in country for cancer clinical research
05 July 2016
Latest figures recently released by produced by the National Cancer Research Network shows that the University Hospital of South Manchester’s (UHSM) Research and Development department is one of the highest recruiters for cancer studies in the country.
 
University of Manchester researchers join forces with US 'cancer moonshot' to develop advanced cancer cell detection technology
29 June 2016
Cancer Research UK researchers based at The University of Manchester and the US government’s National Cancer Institute have announced that two teams will work together to radically accelerate progress against cancer, in one of the first international collaborations inspired by US Vice-President Joe Biden’s Cancer Moonshot.
 
Caroline Dive wins AstraZeneca Prize for Women in Pharmacology
27 June 2016
Professor Caroline Dive has been awarded a prestigious British Pharmaceutical Society prize.
 
Prestigious fellowship award for Manchester clinician scientist
16 June 2016
Dr James O’Connor, a clinician scientist based in the University’s Institute of Cancer Sciences, has become one of the first two medics in the UK to be awarded a Cancer Research UK Advanced Clinician Scientist Fellowship.
 
University of Manchester opens Stoller Biomarker Discovery Centre
15 June 2016
£18 million lab complex will discover the clues to individuals' illnesses.
 
Lung cancer screening pilot up and running in Manchester
14 June 2016
CT scanner units are to be sited in shopping centre car parks in Manchester as part of a UK-first pilot project to try and diagnose lung disease earlier in smokers and former smokers.
 
Scientists identify drugs to target 'Achilles heel' of Chronic Myeloid Leukaemia cells
08 June 2016
New research, by the Universities of Glasgow and Manchester, has revealed an ‘Achilles heel’ of Chronic Myeloid Leukaemia (CML) and found drugs to successfully target this weakness and eradicate the disease in mice.
 
Twice a day radiotherapy halves treatment time and is equally good at treating small cell lung cancer
06 June 2016
A University of Manchester-led trial has found that having radiotherapy once a day for six and a half weeks or twice a day for three weeks is equally good at treating small cell lung cancer.
 
New pre-surgery technique may make colostomy bags redundant for emergency bowel cancer patients
05 June 2016
An expandable tube that unblocks the bowel before surgery could lead to fewer cancer patients – diagnosed as emergencies – needing a colostomy bag.
 
Patients with rare form of bone marrow cancer set to take part in Manchester study thanks to £118,000 charity grant
02 June 2016
A Manchester Royal Infirmary (MRI) consultant is the chief investigator of a new £118,000 grant-funded study aimed at supporting frail patients with myeloma.
 
Cell division and inflammatory disease link revealed
17 May 2016
A ground-breaking study by University of Manchester and Liverpool scientists has identified a new link between inflammation and cell division.
 
If the drug fits: For the first time experts meet to address barriers to personalising drug dosing
17 May 2016
Your shoe fits the size of your foot, so why is your drug dose not tailored to your own personal characteristics in the same way? To answer this question, some of the world's leading experts in health care and pharmaceutical science are coming to Manchester this week.
 
Manchester cancer researchers lead the way in cutting-edge research
13 May 2016
Manchester scientists will play a key role in ground-breaking research into the final stages of cancer.
 
Top Manchester cancer researcher's charity cycle in memory of his colleague
06 May 2016
A pioneering cancer researcher from Manchester is to undertake a 112-mile cycle challenge around the Lake District to raise funds in memory of an inspirational scientist whose work led to the development of new cancer treatments.
 
Reassurance for parents as cancer causing genetic condition risk lower than previously thought
15 April 2016
The odds of children having a genetic condition which causes learning difficulties and tumours have been dramatically cut, thanks to genetic analysis led by The University of Manchester and Central Manchester University Hospitals NHS Foundation Trust.
 
Prestigious fellowship for Manchester clinician scientist
14 April 2016
Dr Amaya Virós, a clinician scientist based at the Cancer Research UK Manchester Institute, has been awarded a Wellcome Trust Intermediate Clinician Scientist Fellowship.
 
Cancer cells turn healthy cells to the ‘dark side’
14 April 2016
Cancer cells use a mutant gene to coerce neighbouring healthy tissue into helping with the disease’s growth and spread, a major new study reports.
 
Royal Manchester Children’s Hospital doctor is UK Chief Investigator for international trial into treatments for children’s leukaemia
11 April 2016
A Royal Manchester Children’s Hospital doctor who is the UK Chief Investigator for an international trial into treatments for childhood leukaemia, has randomised the first UK recruit onto the study.
 
Artist joins forces with Manchester Breast Centre to create new project to support breast cancer
08 April 2016
A Wilmslow artist has created a new project which she hopes will empower those battling breast cancer.
 
Scientists identify possible double whammy to attack leukaemia
07 April 2016
Manchester scientists have identified a potential double drug combination against B-cell acute lymphoblastic leukaemia.
 
Weiss medal awarded to Manchester cancer scientist
07 April 2016
Professor of Radiation Biology, Catharine West, from the Institute of Cancer Sciences has recently been awarded the 2016 Weiss medal by the Association for Radiation Research
 
Manchester Clinical Trials nurse named Oncology Nurse of the Year
06 April 2016
A nurse from The Christie NHS Foundation Trust has been named ‘Oncology Nurse of the Year’ by the British Journal of Nursing.
 
Manchester cancer scientists honoured in Biochemical Society Awards
04 April 2016
Professor Sir Salvador Moncada and Dr Maria Romina Girotti are among the 11 eminent scientists and exceptional early career researchers honoured in 2016.
 
A vision for medicine precision with new disease data link-up
23 March 2016
Vast amounts of data generated by screening patients for diseases like cancer and arthritis at The University of Manchester will now be used to improve treatment and drug safety in partnership with the University of Dundee.
 
Researchers find a genetic new target for most common lung cancer
22 March 2016
Research in Manchester has identified mutations in lung cancer that are key to tumour growth, offering a new way to differentiate and treat some patients with the disease.
 
HIV drug could stop skin cancer becoming drug-resistant
14 March 2016
An HIV drug could stop one of the early changes in skin cancer cells that leads to them becoming resistant to treatment
 
Combination of lapatinib and trastuzumab shrinks HER2 positive breast cancer significantly in 11 days after diagnosis
11 March 2016
Approximately a quarter of women with HER2 positive breast cancer saw their tumours shrink significantly or even disappear, according to results from a clinical trial.
 
TARGET trial finishes its first phase
09 March 2016
The pioneering TARGET study has completed its first phase with encouraging results for conducting virtual biopsies.
 
Blood test may give early warning of skin cancer relapse
07 March 2016
A blood test may be able to sound early warning bells that patients with advanced melanoma skin cancer are relapsing, according to a new study.
 
Delving deeper into breast density
03 March 2016
Researchers in Manchester have been exloring the causes of high breast density that could reveal new ways to prevent the disease.
 
Working together to improve cancer treatment with new proton imaging technology
01 March 2016
Engineers, scientists and clinicians are to working together develop new imaging technology that could provide more accurate cancer treatments.
 
Searching for cancer’s fingerprints gives clues to tumour growth
25 February 2016
A University of Manchester study has shed light on a chain of events that allows tumour cells to thrive in tough environments, identifying potential new ways to diagnose and treat cancer.
 
'Big data' helps to discover key factors driving blood cell specification
25 February 2016
New research involving Manchester scientists has identified key factors that drive blood cell development by recapitulating this process in a culture dish.
 
Manchester Institute biologist takes her research to Parliament
24 February 2016
Kate Hogan, a PhD Student at the Cancer Research UK Manchester Institute, is attending Parliament to present her research.
 
Scientists discover how breast cancer cells spread from blood vessels
10 February 2016
Researchers have identified a protein that controls how breast cancer cells spread around the body, according to a Cancer Research UK-funded study published in Science Signaling.
 
Illuminating one dark spot in the genetics of bowel cancer
09 February 2016
Scientists in Manchester have explored the role of one particular cell signalling protein in bowel cancer, and found that its mutation promotes tumour growth.
 
MCRC building hosts alumni event
05 February 2016
On 4 February – World Cancer Day – the MCRC played host to an evening event for alumni of The University of Manchester.
 
Manchester researcher wins share of £1 million to investigate pancreatic cancer
04 February 2016
Dr Claus Jorgensen from the Cancer Research UK Manchester Institute is one of six scientists to have new research projects funded by Pancreatic Cancer Research Fund.
 
Learning more about treatment resistance in melanoma
26 January 2016
Scientists in Manchester and Glasgow have found that certain melanoma cells change the way they produce energy for growth – offering an insight into drug resistance and a potential way to treat resistant tumours in the clinic.
 

2015

Specialists make breakthrough for bowel cancer patients
17 December 2015
Specialists at The Christie and The University of Manchester have made a breakthrough which will spare patients with cancer of the lower bowel, rectal cancer, from major surgery.
 
Manchester plays a key role in pioneering study that suggests screening for ovarian cancer may save lives
17 December 2015
New results from the world's biggest ovarian cancer screening trial, involving Saint Mary's Hospital in Manchester as one of 13 centres across the UK, suggest that screening based on an annual blood test could help reduce the number of women dying from the disease by around 20%.
 
Imaging test detects aggressive and treatment-resistant cancers
10 December 2015
Scientists have developed a new imaging test that could enable doctors to identify more dangerous tumours before they spread around the body – and tailor treatment accordingly.
 
Breast screening recommendation for women with cancer-causing syndrome
07 December 2015
Researchers in Manchester have found that women with an inherited genetic syndrome are at increased risk of developing breast cancer and should be considered for earlier screening.
 
Exploring routes for lung cancer spread
03 December 2015
Researchers in Manchester have compared different ways to model lung cancer that has spread to other parts of the body, offering a better understanding of how to test potential treatments for advanced disease.
 
Discovered: a cluster of 60 proteins that help cells move and feel
27 November 2015
University of Manchester scientists have discovered a cluster of 60 proteins that allow the body’s cells to react to their environment and communicate with each other.
 
Breast cancer clinic attributes increased uptake of double mastectomies to Angelina Jolie effect
24 November 2015
Researchers at a breast cancer prevention clinic in Manchester have observed an increased uptake of preventative double mastectomies since May 2013, when Angelina Jolie announced that she had undergone the procedure.
 
Schoolgirl cancer vaccination encourages mothers to attend screening
12 November 2015
Manchester researchers have shown that the introduction of the HPV vaccination programme for girls has increased uptake for cervical cancer screening by their mothers.
 
When to go? Personalised web advice for those who suspect lung cancer
09 November 2015
Manchester researchers are trialling a new tool that is designed to get people who may have lung cancer to their doctor earlier.
 
British Association for Cancer Research Translational Award winner
03 November 2015
Romina Girotti, a postdoctoral fellow in the Molecular Oncology group, is a recipient of the British Association for Cancer Research (BACR) Translational Award.
 
Cancer Research UK ‘Future Leaders in Cancer Research’ Prize winner
02 November 2015
John Brognard, leader of the Signalling Networks in Cancer group, was awarded a prestigious Cancer Research UK ‘Future Leaders in Cancer Research’ prize at the annual National Cancer Research Institute (NCRI) Cancer Conference.
 
Heat-activated ‘grenade’ to target cancer
31 October 2015
Researchers have developed cancer drug-packed ‘grenades’ armed with heat sensitive triggers, allowing for treatment to be targeted directly at tumours, according to two studies due to be presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool.
 
Further evidence for potential Achilles heel in pancreatic cancer
28 October 2015
Scientists in Manchester have found more evidence that a specific hallmark of cancer cells could be used to selectively target pancreatic tumours.
 
One hundred cancer patients a year in Manchester benefit from new scan technology
27 October 2015
Researchers in Manchester have used recent advances in PET scanning technology to reduce the radiation dose for both patients and staff by up to 30%, allowing an addition of an annual 100 scans a year.
 
Cancer scientist appointed by President Obama visits Manchester
24 October 2015
Professor Max Wicha a leading breast cancer specialist from the University of Michigan, has been at The University of Manchester to discuss collaborations and deliver a keynote address to scientists.
 
Developing a gel that mimics human breast for cancer research
07 October 2015
Scientists at the Universities of Manchester and Nottingham have been funded to develop a gel that will match many of the biological structures of human breast tissue, to advance cancer research and reduce animal testing.
 
Imaging method has potential to stratify head and neck cancer patients
18 September 2015
Manchester researchers have identified a potential new way to predict which patients with head and neck cancer may benefit most from chemotherapy.
 
New approach found to tackle breast cancer hormone therapy resistance
17 September 2015
University of Manchester researchers funded by Breast Cancer Now have discovered a new explanation as to why women with oestrogen receptor positive (ER+) breast cancer develop resistance to hormone treatment, and a potential new approach to overcome the problem.
 
Leukaemia gene stops blood cells ‘growing up’
14 September 2015
Manchester scientists have identified a gene – FOXC1 – that, if switched on, causes more aggressive cancer in a fifth of acute myeloid leukaemia patients.
 
University and AstraZeneca in £11.5m oncology collaboration
08 September 2015
AstraZeneca and The University of Manchester announce a collaboration harnessing clinical bioinformatics to deliver personalised healthcare for cancer patients.
 
Manchester melanoma scientist awarded prestigious cancer research award
26 August 2015
Maria Romina Girotti, from the Cancer Research UK Manchester Institute, has been awarded the Young Investigator’s Award by ECCO - the European CanCer Organisation - and EJC – the European Journal of Cancer.
 
Cancer Research UK to fund Manchester preclinical study into Biothera immunotherapy combination treatment
18 August 2015
Cancer Research UK will fund preclinical research evaluating the efficacy of Biothera’s investigational cancer immunotherapy Imprime PGG® in combination with monoclonal antibody therapies as a precursor to a phase 1-2 clinical study in rituximab-refractory follicular lymphoma.
 
Manchester Cancer Research Centre on Building of the Year shortlist
06 August 2015
New MCRC building one of three University of Manchester projects to have been shortlisted for the Greater Manchester Building of the Year award – making up half of the total shortlist.
 
University collaboration for early detection of lung cancer
05 August 2015
The University of Manchester has signed a collaboration agreement with Abcodia to perform proteomics studies on a cohort of non-small cell lung cancer cases from the UKCTOCS biobank, with the aim of discovering new blood-based biomarkers for earlier detection of the disease.
 
Manchester lung cancer research features at Royal Society
30 July 2015
Cutting-edge research from Manchester that could improve treatment for lung cancer patients was recently showcased at the Royal Society’s Summer Science Exhibition in London.
 
Overcoming why a new treatment is resisted by lung cancer
29 July 2015
A promising agent for the treatment of cancer has so far had little effect on the most common lung tumours, but new research from The University of Manchester has suggested how this resistance might be overcome.
 
One step closer for predictive ‘liquid biopsy’ in cancer patients
27 July 2015
Scientists in Manchester have developed a robust blood test to allow doctors to better predict which patients will benefit from new therapies.
 
Cell-based therapy one step closer for kidney cancer
22 July 2015
Researchers in Manchester have optimised a new process for generating therapeutic white blood cells for the treatment of kidney cancer, opening the way for large-scale trials to assess the effectiveness and safety of this approach in patients.
 
Anonymous patient's leukaemia genetically mapped to give hope to others
14 July 2015
Manchester scientists have genetically mapped the cancer of a leukaemia patient whose disease was resistant to treatment in order to identify a method of personalising therapy for individuals.
 
New drug combo could make cancer more sensitive to chemo
13 July 2015
Combining chemotherapy with new drugs that target a protein that helps cancer cells to withstand chemotherapy could drastically improve treatment, according to research published in Cancer Cell.
 
Christie consultants become University of Manchester professors
13 July 2015
Two leading consultants from The Christie NHS Foundation Trust, one of Europe's leading cancer centres, have been made professors. Miss Sarah O'Dwyer and Dr Corinne Faivre-Finn have both been honoured with professorships from The University of Manchester.
 
Mapping out the genetic control networks of oesophageal cancer
01 July 2015
Manchester scientists have explored the genetic control networks of oesophageal cancer, leading to a potential way to differentiate between different stages of the disease.
 
Manchester appoints first Chair for Cancer Nursing and Allied Health Professionals
29 June 2015
The Christie NHS Foundation Trust, an international leader in cancer treatment and research, has appointed Janelle Yorke as its first chair for Cancer Nursing and Allied Health professionals (AHP).
 
Manchester to tackle cancer's biggest challenges as new Cancer Research UK Major Centre
26 June 2015
Cancer Research UK announces a further investment of £5 million in Manchester to help transform personalised medicine for cancer treatment and follows last week’s launch of the new cancer research building in Manchester.
 
Cancer patient given just six months to live but is still alive 40 years later
25 June 2015
A cancer patient, who was given just six months to live 40 years ago, is still going strong and looking forward to celebrating her 81st birthday this year, thanks to life-saving research.
 
State-of-the-art research centre will transform cancer treatment
16 June 2015
A new £28.5m research centre that will transform cancer treatment has opened in Manchester.
 
World expert in radiotherapy joins The Christie and The University of Manchester
04 June 2015
One of the world's leading experts in radiotherapy, Marcel van Herk, has moved to Manchester to lead cutting edge radiotherapy research.
 
Mum extends life through clinical trial in Manchester
20 May 2015
A consultant who works in Salford has significantly extended her life by taking part in clinical trials at The Christie.
 
Manchester set for more world leading early phase clinical trials breakthroughs with appointment of new professor
14 May 2015
The Christie NHS Foundation Trust and The University of Manchester have jointly appointed a Strategic Director in experimental cancer medicine.
 
Manchester success in ovarian cancer screening trial
14 May 2015
Researchers at Saint Mary's hospital and The University of Manchester have been instrumental in recruiting over 16,500 women to the largest clinical trial of its kind for ovarian cancer screening.
 
Leading Manchester scientist recognised for excellence in research
11 May 2015
Professor Caroline Dive is one of 48 researchers from across the UK who have been recognised for their contribution to the advancement of medical science by election to the Fellowship of the Academy of Medical Sciences.
 
Psychologists to help Dr Google
07 May 2015
Psychologists are to improve online health information on lung cancer after research showed that family members are more likely to search online to encourage loved ones to seek help.
 
Potential for a more personalised approach to womb cancer
07 May 2015
Manchester doctors have helped show that high-risk womb cancer patients can be genetically profiled to allow them to receive more appropriate treatment.
 
Trial of new ‘resistance-busting’ skin cancer drug begins as first patient receives treatment
05 May 2015
A patient has become the first to receive a new ‘resistance-busting’ experimental skin cancer drug with the launch of a phase I clinical trial.
 
Profiling approach to enable right lung cancer treatment match
05 May 2015
Researchers have tested a new way to genetically profile lung cancer samples, potentially allowing doctors to more easily identify the most appropriate treatment for patients.
 
Cancer scan could remove need for radiotherapy for cured patients
23 April 2015
A trial led from Manchester has suggested that in patients with early stage Hodgkin lymphoma the late effects of radiotherapy could be reduced by using a scan to determine those who actually need it.
 
Manchester joins European consortium to develop liquid biopsies
21 April 2015
Scientists from the Cancer Research UK Manchester Institute will participate in CANCER-ID, an international project to validate blood-based biomarkers for cancer.
 
New drug combination shows promise for breaking breast cancer resistance
20 April 2015
Researchers from Manchester working with drug development company Evgen Pharma, have developed a new combination of drugs which could overcome treatment resistance and relapse in breast cancer.
 
Potential for prediction of progression for early form of breast cancer
15 April 2015
Scientists in Manchester have identified a way to potentially predict which patients with an early form of breast cancer will experience disease progression.
 
Melanoma’s ‘safe haven’ targeted for shut-down
13 April 2015
Melanoma cells become drug resistant by using surrounding healthy cells to provide a ‘safe haven’ from treatment, according to new research.
 
Study suggests new role for gene in suppressing cancer
06 April 2015
Scientists in Manchester have discovered that a previously known gene also helps cells divide normally and that its absence can cause tumours.
 
Consortium signs deal with Basilea to develop resistance-busting cancer drugs
01 April 2015
A group of academic organisations and funders has entered an agreement with biopharmaceutical company Basilea Pharmaceutica Ltd. to progress a new family of cancer drugs designed to block several key cancer-causing proteins at once.
 
Blood test could help bowel cancer patients avoid drug side-effects
25 March 2015
Manchester researchers have provided early evidence to suggest that a blood test could be used to identify bowel cancer patients that may benefit from more intensive chemotherapy.
 
Survey launched for womb cancer research
23 March 2015
A national group of researchers, medical bodies and charities, led by The University of Manchester is looking for help in setting the top priorities for fighting womb cancer
 
TORC-ing is the key to nitrogen stress
13 March 2015
Manchester scientists have shown how cells respond to changes in nitrogen levels – indicating how cancer cells may be able to survive in a challenging tissue environment.
 
Understanding of cell enzyme flipped on its head
09 March 2015
Researchers from Manchester, working with scientists in California, have found that certain molecules long thought to promote cancer growth, in fact suppress tumours, suggesting that therapeutic approaches should aim to restore, rather than block, their activity.
 
Insight into cancer-related inflammation could offer new treatment approach
04 March 2015
Researchers in Manchester have identified a key molecule that controls tissue inflammation and found new clues on its link with the development of cancer.
 
Christie announces Roger Spencer as Chief Executive
04 March 2015
The Christie has appointed Roger Spencer as its new Chief Executive.
 
Innovative approach to assessing effectiveness of anti-cancer drugs
27 February 2015
Manchester scientists have a developed a new method to monitor the effect of anti-cancer drugs on very rare leukaemia stem cells. The approach potentially allows doctors to screen patients and personalise their treatment.
 
Graphene shows potential as novel anti-cancer therapeutic strategy
25 February 2015
Manchester scientists have used graphene to target and neutralise cancer stem cells while not harming other cells.
 
Manchester researcher takes her science to Parliament
23 February 2015
Dr Maria Romina Girotti, a Postdoctoral Research Fellow at the Cancer Research UK Manchester Institute, will attend Parliament to present her science to a range of politicians and a panel of expert judges.
 
Heating targeted cancer drugs increases uptake in tumour cells
11 February 2015
Manchester scientists have found that gentle heating of targeted nano-sized drug parcels results in a more effective delivery to tumour cells – resulting in an improvement in survival rates.
 
Cell reprogramming offers hope for blood disease treatment
05 February 2015
Manchester scientists have developed a method to create blood cells that perfectly match individual patients, offering a new treatment approach for blood cancers and other diseases.
 
New approach for ovarian cancer at The Christie has given patient hope
03 February 2015
A new clinical trial for ovarian cancer has given a retired supply teacher from North Wales fresh hope in her battle against ovarian cancer.
 
Schoolgirl comment points to antibiotics as new cancer treatments
28 January 2015
A way to eradicate cancer stem cells, using the side-effects of commonly used antibiotics, has been discovered by a University of Manchester researcher following a conversation with his young daughter.
 
Cancer research computing to benefit from being ‘up in the cloud’
27 January 2015
Manchester computer scientists have proposed a new approach to linking together the wealth of data generated by cancer research – the aim is to provide a more complete picture that will aid the implementation of precision medicine.
 
Chair in Proton Therapy Physics appointed for Proton Therapy Centre in Manchester
12 January 2015
Manchester is set to play a key role in the development of proton beam therapy in the UK with the arrival of Professor Karen Kirkby as Chair in Proton Therapy Physics.
 
Tumour-blocking role found for cell regulation molecule
09 January 2015
Manchester scientists have recently explored the role of a protein in regulating tumour development and found that it suppresses liver cancer growth in the lab.
 
Potential new tool to monitor radiotherapy side effects
07 January 2015
Researchers in Manchester have investigated a patient-centred approach to assessing the side effects of radiotherapy and have shown that it may be able to improve the detection and management of treatment-related toxicity.
 

2014

Scientists zero in on how lung cancer spreads
24 December 2014
Cancer Research UK scientists have taken microscopic images revealing that the protein ties tethering cells together are severed in lung cancer cells – meaning they can break loose and spread.
 
Manchester set to deliver world-leading genomics project in fight against cancer
22 December 2014
NHS England has today announced eleven centres across the country that will lead the way in delivering the 100,000 Genomes Project, one of which will be in Manchester.
 
MAHSC appoints new clinical director
19 December 2014
Manchester Academic Health Science Centre (MAHSC) has appointed Professor Peter Trainer, a leading endocrinologist at The Christie, as Clinical Director.
 
New insight into cancer drug resistance
18 December 2014
Manchester scientists have helped to improve our understanding of how leukaemia cells become resistant to multiple anti-cancer drugs.
 
New equipment lets Manchester cancer scientists look closer than ever before
16 December 2014
Manchester scientists now have access to new research equipment that lets them interrogate tumour tissue samples more thoroughly than ever before.
 
New targeted drugs could treat drug-resistant skin cancer
11 December 2014
A brand new family of cancer drugs designed to block several key cancer-causing proteins at once could potentially treat incurable skin cancers, a major new study reports.
 
Molecular tag team revealed to control cell division
10 December 2014
Manchester scientists have explored the role of three molecules in controlling the process of cell division in a bid to gain new insight into the transmission of vital signals from a cell’s exterior to its interior.
 
Manchester sees first-in-man trial of potential new drug
09 December 2014
Doctors in Manchester have partnered with researchers in London to carry out a study of a potential new anti-cancer drug.
 
More evidence for impact of lung cancer targeted therapy from trial
04 December 2014
An international study involving Manchester researchers has found that for previously untreated lung cancer patients with a particular genetic change, a new targeted therapy is better than standard chemotherapy.
 
Risk stratification model may aid lung cancer staging and treatment decisions
03 December 2014
Manchester researchers have explored a risk stratification model based on lymph node characteristics and have shown a high level of confidence in confirming a true lack of lung cancer in the lymph nodes of patients with a negative lymph node sample.
 
New cause of child brain tumour condition identified
02 December 2014
Doctors and scientists from The University of Manchester have identified changes in a gene, which can increase the risk of developing brain tumours in children with a rare inherited condition called Gorlin syndrome.
 
Current approach for detecting BRCA gene mutations misses people at high risk of cancer
01 December 2014
Research led by a University of Manchester academic on the BRCA gene mutation in the Jewish population shows that the current process of identifying people which relies on assessing someone’s family history, misses half the people who have the mutation and are at risk of developing cancer.
 
Major makeover for tissue analysis lab will benefit cancer researchers
26 November 2014
Scientists in Manchester are benefitting from a major makeover of tissue-based research facilities that they can use for ground-breaking research.
 
Researchers identify new ways to drain cancer’s ‘fuel tank’
25 November 2014
Scientists in Manchester have discovered a potential weakness in cancer’s ability to return or become resistant to treatment, by targeting the ‘fuel’ part of stem cells which allows tumours to grow.
 
£50M CRT Pioneer Fund announces investment to develop lung cancer drugs at Cancer Research UK Manchester Institute
21 November 2014
The Cancer Research Technology Pioneer Fund (CPF) have announced a collaboration with the Cancer Research UK Manchester Institute Drug Discovery Unit to develop a promising class of drugs called RET inhibitors to treat cancer.
 
Simple test could identify best treatment approach for neck cancer patients
20 November 2014
Manchester researchers have identified a potential test to predict which patients with neck cancer may not benefit from conventional treatment and may require a different therapeutic approach.
 
Study spots signature of early breast cancer
19 November 2014
Scientists in Manchester have helped to identify a ‘signature’ of characteristic genetic changes in breast cells that could indicate the first steps towards cancer.
 
Mind the gap – how new insight into cells could lead to better cancer drugs
19 November 2014
A new insight into immune cells by scientists at The University of Manchester could lead to more effective drug treatments.
 
New insight into action of cancer-targeting drug
17 November 2014
Scientists in Manchester, working with colleagues in Sweden, have identified how a new anti-cancer drug targets tumour cells over healthy cells.
 
DNA ‘blind spots’ may hide cancer-causing mistakes
14 November 2014
Manchester scientists have found more than 400 ‘blind spots’ in DNA which could hide cancer-causing gene faults.
 
Manchester trial recruitment top of the league
11 November 2014
Researchers in Manchester are leading the way in recruiting cancer patients to clinical trials in radiotherapy.
 
Simple and cheap method to test for cancer-causing syndrome risk
10 November 2014
Manchester scientists are investigating a method to better identify patients who may have Lynch syndrome – a condition that greatly increases the risk of developing bowel cancer.
 
Rapid and accurate process will drive forward understanding of cancer biology
07 November 2014
Scientists in Manchester have developed a new method to quickly and more accurately investigate vital cell communication – a process that often goes wrong in cancer.
 
Further evidence of potential for new anti-cancer drug
06 November 2014
Manchester scientists have shown that a new drug inhibits the growth of tumours in the lab and that its effectiveness is improved by combining it with radiotherapy – suggesting a new approach that could be used in the clinic.
 
Study gives insight into breast cancer recurrence
05 November 2014
Work by University of Manchester scientists has explored what allows some cases of Ductal Carcinoma in Situ (DCIS), a non-invasive form of breast cancer, to resist treatment and come back, as well as identifying a potential new target to improve the effectiveness of radiotherapy.
 
Increased understanding of early blood vessel cells
30 October 2014
Scientists in Manchester have further explored the properties of cells that could have an application in anti-cancer therapies.
 
No survival benefit from combination therapy for lung cancer patients with multiple brain metastases
27 October 2014
A study involving doctors from Manchester, working alongside researchers from UCL and other UK hospitals, has found no benefit for a combined treatment approach in lung cancer patients with secondary brain tumours.
 
When cancer meets fashion
27 October 2014
A Manchester-based scientist has teamed up with a Pennsylvanian fashion designer to create a dress showing how prostate cancer spreads in the body.
 
Cancer research in Manchester to benefit from Medical Research Council awards
23 October 2014
The University of Manchester has been awarded £24 million for three large projects, two of which will drive forward the development of clinical sample testing and improve our understanding of basic cancer cell biology.
 
Potential new approach to treating head and neck cancer
17 October 2014
A study in Manchester has explored a method to intensify the radiation dose for patients with head and neck cancer and shown that their new approach is safe and well-tolerated – offering the potential to better treat this disease.
 
Improving outcomes for childhood leukaemia
16 October 2014
A Manchester-led study looking at controlling relapse in children with leukaemia has recently reported its findings – giving doctors more information on the best treatment approach for the disease.
 
Manchester study investigates methods for lung cancer sampling
09 October 2014
Researchers in Manchester have investigated which patients with lung cancer could most benefit from undergoing an alternative method for tissue biopsy – potentially reducing the risk of a collapsed lung for some patients.
 
Study shows breast cells can wake from an extended sleep
06 October 2014
Research by scientists in Manchester has found that breast tissue cells can reawaken and continue to grow following treatment – findings that have implications for the design of breast cancer therapies.
 
Immunotherapy could stop resistance to radiotherapy
01 October 2014
Treating cancers with immunotherapy and radiotherapy at the same time could stop them from becoming resistant to treatment.
 
Dose boost safe for prostate cancer patients
30 September 2014
A study by Manchester researchers has shown that a boost dose of radiotherapy delivered to patients with higher risk prostate cancer is well tolerated.
 
The ‘Angelina Effect’ was not only immediate, but also long-lasting
29 September 2014
Referrals for genetic counselling and testing for breast cancer risk more than doubled across the UK, after actress Angelina Jolie announced in May 2013 that she tested positive for a BRCA1 gene mutation and underwent a double mastectomy.
 
New clues on how blood cell creation is controlled
26 September 2014
Manchester scientists have discovered more about the role of a particular gene in the formation of blood cells – work that could help improve understanding of cancer development.
 
Calming down immune cells could hold key to melanoma treatment
25 September 2014
Immune cells may be responsible for drug resistance in melanoma patients, according to research published in Cancer Discovery.
 
New method to increase chance of survival for some lung cancer patients
16 September 2014
Scientists from The University of Manchester have found that offering radiotherapy to patients with small cell lung cancer in addition to chemotherapy improves their chances of survival two years after treatment.
 
Researchers identify why some melanoma cells respond better to drugs
15 September 2014
Researchers in Manchester have been exploring why some patients with melanoma respond better than others to chemotherapy and looking at whether it is possible to predict which patients are most likely to benefit from treatment.
 
New Director of Research Operations and Business for the Manchester Cancer Research Centre
12 September 2014
Dr Nigel Brooks, former Senior Director at AstraZeneca, has joined the Manchester Cancer Research Centre as Director of Research Operations and Business.
 
New blood test could offer more tailored treatment of ovarian cancer
05 September 2014
A new blood test allowing doctors to predict which ovarian cancer patients will respond to particular types of treatment is a step closer following a new study by Manchester scientists.
 
Study shows potential method to better control lung cancer using radiotherapy
29 August 2014
Manchester scientists are working out how to safely increase the radiotherapy dose given to lung cancer patients – potentially offering improved local control and survival.
 
Manchester Professor is new President of European Association of Cancer Research
29 August 2014
The European Association of Cancer Research has appointed University of Manchester Professor Richard Marais as its new President sitting from 2014 to 2016.
 
New tool to probe cancer’s molecular make-up
26 August 2014
Scientists have shown how to better identify and measure vital molecules that control cell behaviour – paving the way for improved tools for diagnosis, prediction and monitoring of cancer.
 
Scientists learn more about rare skin cancer that killed Bob Marley
20 August 2014
Cancer Research UK-funded scientists in Manchester have discovered that acral melanomas – the rare type of skin cancer that caused reggae musician Bob Marley’s death – are genetically distinct from other more common types of skin cancer, according to a study published in the journal Pigment Cell & Melanoma Research.
 
Yeast studies shed light on cancer cell processes
11 August 2014
Manchester scientists are working out how to make the most of yeast cells in experiments looking at fundamental biological processes – potentially giving a greater insight into what goes wrong in cancer.
 
Lung cancer diagnosis tool shown to be safe and effective for older patients
05 August 2014
A recent study in Manchester has found that a procedure to take tissue samples from lung cancer patients can be used safely in the elderly – allowing doctors to make a more accurate diagnosis and to choose appropriate treatment.
 
Manchester scientists pinpoint bladder cancer patients who could benefit from 'tumour softening' treatment
30 July 2014
Scientists in Manchester have identified a protein that could help doctors decide which bladder cancer patients would benefit from a treatment that makes radiotherapy more effective, according to a study published in the British Journal of Cancer.
 
Piggy-backing cells hold clue to skin cancer growth
24 July 2014
Skin cancer cells work together to spread further and faster, according to a new study.
 
Manchester experts chosen to aid development of cutting-edge radiotherapy technology
22 July 2014
Cancer patients in the North West are set to benefit from a revolutionary new treatment that will aim to shorten treatment times, reduce side-effects and improve their chances of beating the disease.
 
New device shows potential for leukaemia screening
17 July 2014
Scientists from the Manchester Institute of Biotechnology at The University of Manchester – part of the Manchester Cancer Research Centre – have developed a potential new tool to screen blood cancers to help with diagnosis and treatment planning.
 
Key gene variations predict patients’ risk for radiotherapy side effects
15 July 2014
Key genetic variants may affect how cancer patients respond to radiation treatments, according to a study, involving researchers at The University of Manchester, published recently in the journal Nature Genetics.
 
Yeast cell response to stress may give clues to cancer development
14 July 2014
Manchester scientists are investigating how yeast cells respond to environmental stress in order to gain insight into processes that could help our understanding of cancer development.
 
New drug active against most aggressive type of lung cancer cells
11 July 2014
Manchester scientists have shown that a new drug could prove useful in treating small cell lung cancer - the most aggressive form of lung cancer.
 
Chemotherapy shown to affect memory in young cancer patients
07 July 2014
A significant number of young cancer patients suffer memory related side effects from chemotherapy according to a study by The University of Manchester to be announced at Teenage Cancer Trust’s International Conference on Teenage and Young Adult Cancer, Royal Society of Medicine.
 
Cancer Research UK launches visionary new Lung Cancer Centre of Excellence
01 July 2014
Cancer Research UK is bringing together leading researchers from London and Manchester in a groundbreaking new Lung Cancer Centre of Excellence.
 
Researchers discover how 'wriggling' skin cancer cells go on the move
25 June 2014
Scientists at the Cancer Research UK Manchester Institute, The University of Manchester and King’s College London have discovered a new way that melanoma skin cancer cells can invade healthy tissue and spread round the body.
 
Study investigates online information available to lung cancer patients
19 June 2014
Researchers from The University of Manchester have begun a study to look at the online information available to lung cancer patients in an era of diagnosis by google.
 
Manchester scientists reveal that signalling protein plays different roles in breast cancer and normal cells
18 June 2014
A new study by Manchester scientists has shown for the first time that a particular protein has contrasting effects in normal and cancerous breast stem cells – meaning it could prove useful in the development of more targeted treatments for breast cancer.
 
Surgeon and father tour North West hospitals by bike to raise cancer awareness
12 June 2014
The father of a graduate who died from ovarian cancer has teamed up with The University of Manchester medic who treated her for a 200 mile sponsored cycle ride visiting seven hospitals in the North West.
 
New clues to skin cancer development show sunscreen is not enough
11 June 2014
Scientists have shown that sunscreen cannot be relied upon alone to prevent malignant melanoma, the most deadly form of skin cancer.
 
New insight into drug resistance in metastatic melanoma
03 June 2014
A study by scientists in Manchester has shown how melanoma drugs can cause the cancer to progress once a patient has stopped responding to treatment.
 
‘Liquid biopsy’ offers new way to track lung cancer
02 June 2014
Scientists have shown how a lung cancer patient’s blood sample could be used to monitor and predict their response to treatment – paving the way for personalised medicine for the disease.
 
Presenting with symptoms may make an early form of breast cancer more likely to be invasive
30 May 2014
Doctors should be more aware of the potential for invasive disease in patients presenting with symptoms of an early form of breast cancer, compared with those whose disease is detected through screening.
 
New study aims to improve treatment options for elderly cancer patients
29 May 2014
Researchers from Manchester are leading a new national study to test a method to improve the effectiveness of radiotherapy in head-and-neck cancer, especially for older patients.
 
Scientists find new way to combat drug resistance in skin cancer
22 May 2014
Rapid resistance to vemurafenib – a treatment for a type of advanced melanoma, the deadliest form of skin cancer – could be prevented by blocking a druggable family of proteins.
 
Researchers identify new protein linked to leukaemia growth
15 May 2014
Research by Manchester scientists has discovered a molecule that plays a key role in leukaemia.
 
Deprivation in North West linked to lower uptake of cervical cancer vaccination
14 May 2014
Women and girls living in the most deprived areas of North West England are less likely to take part in cervical cancer screening and prevention programmes, according to a recent Manchester study.
 
New agent may enhance effectiveness of radiotherapy
13 May 2014
Scientists from The University of Manchester – part of the Manchester Cancer Research Centre - have demonstrated the potential of a drug to improve the effectiveness of radiotherapy in stopping tumour growth.
 
Researchers identify potential new strategy to treat ovarian cancer
25 April 2014
Scientists studying cancerous tumour tissues in a laboratory believe they have identified a potential new strategy to treat ovarian cancer – which affects around 7,000 women in the UK each year.
 
Scientists find way to target cells resistant to chemotherapy
24 April 2014
Scientists from The University of Manchester have identified a way to sensitise cancer cells to chemotherapy - making them more open to treatment.
 
New method to analyse how cancer cells die
23 April 2014
Manchester scientists have improved a way of analysing how cancer spreads and how effective drugs are at killing the cells.
 
Cholesterol unlocks clues to prostate cancer spread
16 April 2014
Scientists have uncovered a link between cholesterol and prostate cancer’s ability to spread to the bones in a study published in the British Journal of Cancer.
 
Manchester study finds role for genetic test in parathyroid cancer diagnosis
09 April 2014
Scientists in Manchester have shown that a simple test could improve the diagnosis of parathyroid cancer.
 
New Director of Institute for Cancer Sciences
08 April 2014
One of the world's most cited scientists - knighted by the Queen for services to the subject - has taken the helm as Director at The University of Manchester's Institute for Cancer Sciences.
 
Ovarian cancer survivor backs study to improve screening
31 March 2014
A woman from Manchester has warned other women of the need to be aware of ovarian cancer, especially if they have a family history of the disease, as part of Ovarian Cancer Awareness Month.
 
Keeping track of metastatic melanoma
24 March 2014
Manchester cancer scientists have revealed the potential of a less invasive technique to monitor how metastatic melanoma responds to treatment, in real-time.
 
More frequent mammograms might benefit a third of women, study shows
21 March 2014
A study of over 50,000 women participating in the UK NHS Breast Screening Programme has found that, while three-yearly screening intervals are appropriate for the majority of women, approximately one third of women are at higher risk of developing cancer and might benefit from more frequent mammograms.
 
Lung cancer rates climb in women in the North West while falling in men
20 March 2014
In the North West, lung cancer rates in women have risen by nearly a quarter (23 per cent) over the last twenty years according to new Cancer Research UK figures* released today.
 
Cell-producing lab meets highest standards for cancer therapy development
18 March 2014
A new way of targeting cancer cells is now being tested in the clinic thanks to recent work by Manchester scientists.
 
Institute appoints new cancer research group leaders
12 March 2014
Two new group leaders are set to join the Cancer Research UK Manchester Institute at The University of Manchester – part of the Manchester Cancer Research Centre.
 
Could sticky cells cause drug resistance in chronic blood cancer?
10 March 2014
Researchers in Manchester have investigated the stickiness of leukaemia cells, and whether this is linked to drug resistance.
 
Manchester study explores surgery for older breast cancer patients
07 March 2014
Age is a major risk factor for breast cancer in women, with 80 per cent of breast cancer cases diagnosed in women over 50 and a third of all breast cancers diagnosed in women over 70.
 
New approach to prostate cancer screening needed
07 March 2014
The UK needs to invest in testing for those men most at risk of prostate cancer rather than follow a cast-the-net-wide approach targeting the whole population, a leading scientist from The University of Manchester has argued at an international conference this week.
 
Scientists discover new protein involved in lung cancer
28 February 2014
Scientists from The University of Manchester – part of the Manchester Cancer Research Centre (MCRC) - have discovered a new protein that is involved in cancer and inflammation in lung tissue.
 
Health sessions for MCRC construction workers
27 February 2014
On-site workers constructing the new Manchester Cancer Research Centre building have been taking part in a health programme run by Clare Dickinson, the Cancer Research UK Lead Nurse for Manchester based at The Christie.
 
Scientists explore promising new option for first line of attack in lymphoma
25 February 2014
A study led by University of Manchester scientists has shown promising results for a new treatment approach in follicular lymphoma.
 
Fighting the invasion: what makes lung cancer cells spread?
17 February 2014
Scientists in Manchester are a step closer to understanding how lung cancer cells are able to spread into surrounding tissue and now believe that specialised channels that let sodium ions move into the cell play a crucial role.
 
New study explains how dense breast tissue drives the early stages of cancer
14 February 2014
Scientists from The University of Manchester working with IBM Research have identified a key biological mechanism that for the first time explains why women with dense breast tissue are at greater risk of developing breast cancer.
 
Efficient treatment a step closer in the fight against cancer-causing herpes
13 February 2014
Herpes virus proteins are more ‘spaghetti-like’ than previously thought, which provides a vital clue in the search for an efficient treatment against a type of herpes which causes a form of cancer known as Kaposi’s sarcoma.
 
Manchester along with Belfast has received £5million to host one of the UK’s first Movember Centres of Excellence in partnership with Prostate Cancer UK
13 February 2014
The Movember Foundation and Prostate Cancer UK have announced the launch of the UK’s first ever Centres of Excellence programme in prostate cancer research.
 
Alcohol-breakdown molecule may play a role in breast cancer development
12 February 2014
New research looking at the biological process involved in breast cancer development has strengthened the argument for a potential link between alcohol consumption and the disease.
 
Cancer deaths higher in Greater Manchester compared to rest of UK
05 February 2014
Every day 18 people die from cancer in Greater Manchester – around 6,500 a year – making the death toll around 10 per cent higher than the UK average*, according to the latest Cancer Research UK figures out today (Wednesday).
 
Cancer Research UK launches trial of new lymphoma treatment in Manchester
29 January 2014
Cancer Research UK’s Drug Development Office (DDO) - working with The University of Manchester - has launched a new clinical trial to treat lymphoma patients using the body’s own immune system to attack cancerous B-cells growing out of control.
 
Simple protein test could improve prediction of survival rates for patients with head and neck cancer
24 January 2014
Scientists from The University of Manchester – part of the Manchester Cancer Research Centre - used a simple protein test that could prove more useful in predicting survival chances for patients with head-and-neck cancer compared to existing methods.
 
Researchers gain greater understanding of processes involved in the control of blood cell growth
23 January 2014
Scientists in Manchester have gained new insight into a possible treatment target for leukaemia by looking at what makes blood stem cells stop replicating.
 
Practice-changing study shows that targeted treatment is better than chemotherapy in some lung cancer patients
10 January 2014
Patients with lung cancer who also have a specific gene rearrangement do better on a new targeted therapy compared with standard chemotherapy, according a study by academics from the Manchester Cancer Research Centre.
 
Manchester scientists receive £1.8 million for leukaemia research
07 January 2014
Scientists at The University of Manchester – part of the Manchester Cancer Research Centre - have been awarded a £1.8 million grant by the blood cancer charity Leukaemia and Lymphoma Research, to improve treatments for leukaemia patients.
 

2013

Researchers find potential new treatment approach for pancreatic cancer
20 December 2013
Scientists from The University of Manchester – part of the Manchester Cancer Research Centre - believe they have discovered a new way to make chemotherapy treatment more effective for pancreatic cancer patients.
 
MCRC scientists chosen to run new industry-academia network
19 December 2013
Researchers from The University of Manchester – part of the Manchester Cancer Research Centre - have been chosen to lead new research network linking industry and academia set up to help develop new drugs, including anticancer drugs.
 
New research equipment will help Manchester scientists understand how leukaemia cells survive chemotherapy
18 December 2013
Manchester scientists aim to identify key characteristics that help blood cancer cells survive after chemotherapy using a new piece of research equipment that can amplify DNA from a single cancer cell.
 
Understanding the genetics of melanoma of the eye
18 December 2013
Scientists in Manchester are getting new insight into the genetics of cancer of the eye by working out the entire genetic code of the disease.
 
Research backs risk-reduction surgery for ovarian cancer
17 December 2013
A study by Manchester scientists backs preventative surgery to improve survival for women who are at greater risk of getting ovarian cancer and suggests it appears helpful for women at risk of getting breast cancer because of genetic faults.
 
Manchester Centre for Cellular Metabolism unites diverse disciplines
09 December 2013
The recent realisation that many human diseases including cancer, obesity and diabetes share a common cause in metabolic imbalance has propelled the establishment of a new Manchester Centre for Cellular Metabolism (MCCM) based at The University of Manchester.
 
Collaboration to generate new cancer drugs
29 November 2013
Cancer Research Technology, the commercial arm of Cancer Research UK, and the University of Manchester today announced a research agreement with GlaxoSmithKline (GSK) to generate new cancer drugs in the field of epigenetics.
 
Success for Manchester’s Academic Health Science Centre bid
29 November 2013
Manchester’s aim to become a leading international centre for turning innovative research into improved health for people locally and globally has received a major boost.
 
Manchester to benefit from Cancer Research UK £100m investment in research centres across the UK
21 November 2013
Manchester scientists will benefit from a Cancer Research UK investment of over £100 million across cutting-edge research centres to help get new treatments and diagnostics to cancer patients sooner.
 
New scan gives insight into tumour oxygenation
13 November 2013
Manchester scientists have developed a new imaging method that could help doctors choose the best treatment for individual patients by measuring how much oxygen is in their tumour.
 
Milestone celebrated at the Manchester Cancer Research Centre
12 November 2013
A topping out ceremony was held this week to mark construction of the highest point of the new £28.5m Manchester Cancer Research Centre (MCRC) building.
 
Hands Up For Creating Groundbreaking Research of the Future
11 November 2013
A GANG of brave cancer survivors and those who have lost loved ones to the disease will leave a lasting impression on the new £28.5m Manchester Cancer Research Centre.
 
Oxygen levels in tumours affect response to treatment
08 November 2013
The genetic make-up of a patient’s tumour could be used to personalise their treatment, and help to decide whether they would benefit from receiving additional drugs as part of their radiotherapy programme, according to a recent study involving scientists from the Manchester Cancer Research Centre.
 
Manchester prostate cancer deaths fall by almost a fifth in just under 20 years
01 November 2013
Death rates from prostate cancer in Greater Manchester have fallen by 18 per cent since the mid 1990s according to new figures* released by Cancer Research UK.
 
Study finds "alarmingly" low survival of Kenyan women with cervical cancer
31 October 2013
Less than 7% of cervical cancer patients in Kenya are getting the optimum treatment needed to eradicate the disease, leading to unnecessary deaths - a study by The University of Manchester scientists reveals.
 
Local schools get creative with cells to mark Manchester’s new cancer research centre
28 October 2013
Two local primary schools have taken part in a collaborative art-science project to mark the establishment of the new Manchester Cancer Research Centre (MCRC) research building as a milestone in cancer research in the city.
 
Cancer imaging centres get £35 million boost
24 October 2013
Cancer imaging is set to get a major boost from a £35 million nationwide initiative to develop cutting edge imaging technologies for basic and clinical cancer research – with Manchester playing a major role.
 
Women fighting cancer launch fundraising for Manchester Cancer Research Centre
22 October 2013
Women fighting cancer share their hopes for More Tomorrows through unique artwork on their heads.
 
Manchester Cancer Research Centre at Manchester Science Festival
15 October 2013
The Manchester Cancer Research Centre (MCRC) is hosting two public events in October - a screening of “The Enemy Within”, a film about the history of cancer research in Manchester, and a behind the scenes lab tour - both of which are part of Manchester Science Festival (24 October - 3 November 2013).
 
New Manchester home for state-of-the-art research equipment thanks to funding boost
02 October 2013
Manchester Cancer Research Centre (MCRC) scientists have taken delivery of three new sophisticated research tools thanks to funding from the HEFCE UK Research Partnership Investment Fund (UKRPIF).
 
Cancer Research UK appoints local businessman to pioneering executive role
01 October 2013
A leading North West businessman and award winning entrepreneur has been appointed as the very first Executive Patron of the groundbreaking “More Tomorrows” campaign.
 
Secret life of molecules exposed by Manchester cancer scientists
01 October 2013
Scientists in Manchester will be able to explore cells and proteins involved in cancer by looking at them closer than ever before thanks to a new state-of-the-art super resolution imaging machine, funded primarily by the Manchester Cancer Research Centre (MCRC).
 
New European study will devise ways to reduce the side-effects of radiotherapy
13 September 2013
Scientists from The University of Manchester are leading a new European study to come up with methods to reduce the unwanted side-effects of radiotherapy and improve cancer treatment.
 
Manchester and Leicester researchers hope to discover the perfect amount of sun for your skin
04 September 2013
Researchers from The University of Manchester have teamed up with experts in Leicester to study how much skin damage occurs at different light intensities and on different tones of skins.
 
Cancer research goes green
01 September 2013
Cancer research in Manchester is going green thanks to the North West’s latest research building, which has been carefully designed to incorporate a range of environmentally-friendly features.
 
Manchester team to lead the world in fungal infection research
14 August 2013
The University of Manchester has invested in building a world-leading research group to tackle a problem that is largely unrecognised yet affects millions of people each year.
 
Keep safe in the sun advice for rugby players and supporters
06 August 2013
Staff from The University of Manchester and Salford Royal NHS Foundation Trust’s dermatology research team will be ensuring Salford City Reds fans don’t let their skin match the club’s name at their game on Friday 9 August.
 
Manchester and Israel partnership to boost stem cell and cancer research
26 July 2013
Leading researchers from The University of Manchester and Israel's Institute of Technology are to work together in the hunt for cures to cancer and genetic illnesses.
 
Pioneering research of the future inspires charity garden
24 July 2013
A brave cancer survivor retraced her footsteps in helping to build a new £28.5m research centre when she officially opened the Cancer Research UK garden at RHS Tatton.
 
8 in 10 now survive skin cancer
22 July 2013
MORE than eight out of 10 people diagnosed with malignant melanoma, the most dangerous form of skin cancer, will now survive the disease, compared to only around five in 10 in the early 70s, according to a new report* released today (Monday) by Cancer Research UK.
 
Manchester at heart of new research to revolutionise lung cancer understanding
18 July 2013
Manchester is set to play a key role in a world-first Cancer Research UK study that will unlock lung cancer’s secrets.
 
Genetic screen finds new treatment targets for lung cancer
08 July 2013
Cancer Research UK scientists are the first to use an efficient new screening strategy to identify gene faults in tumour cells that are possible drug targets for the most common form of lung cancer, according to new research published in PNAS, today (Monday).
 
Global bid to bring world’s leading cancer minds to Manchester
08 July 2013
A global recruitment drive to bring 20 of the world’s best cancer experts and their teams to Manchester is now underway.
 
University staff survey raises funds for new MCRC research building
27 June 2013
The Manchester Cancer Research Centre (MCRC) has received more than £4,700 – thanks to The University of Manchester’s Staff Survey 2013. The donations made to The Christie for £2,037 and Cancer Research UK for £2,666 have boosted the ‘More Tomorrows’ campaign, which was set up by MCRC partners to raise funds for the new research building.
 
Early mammograms in young women at increased breast cancer risk may save lives
17 June 2013
Findings, published in journal Familial Cancer, show women under the age of 40 at higher risk of breast cancer who went for mammographic screening had their breast cancer detected at an earlier, more easily treatable stage, potentially improving their chance of survival.
 
CRT, University and Astrazeneca work together to seek new cancer drugs
14 June 2013
Cancer Research Technology, the commercial arm of Cancer Research UK, the University of Manchester and AstraZeneca announce two agreements to seek new cancer drugs.
 
Sunbeds blamed for high skin cancer rates in young women in North West, study reveals
12 June 2013
Rates of the deadliest form of skin cancer are unusually high in young women in the North West of England, with sunbeds and cheap holidays to blame, according to research published today in the British Journal of Dermatology.
 
DNA sequencing reveals mucosal melanoma’s bullseye
07 June 2013
Scientists may have found a molecular 'bullseye' for a rare form of melanoma, opening up opportunities for new targeted treatment, according to new research* being published in the Journal of Pathology today (Friday).
 
Manchester drives groundbreaking collaboration for first in man trials
17 May 2013
As International Clinical Trials day (May 20th) is celebrated around the world, Manchester scientists are driving two groundbreaking early-phase trials that buck tradition by bringing together Asian and Western research sites.
 
Manchester appoints world-leading academic to help bring graphene closer to medicine
07 May 2013
The University of Manchester has today announced the appointment of a world-leading academic, who is playing a pivotal role in nanomedicine - a growing field with potential to benefit patients suffering from neurodegenerative disease and cancer.
 
Some types of papilloma virus might prevent cervical cancer
10 April 2013
Certain types of papilloma virus might actually prevent cervical cancer, according to a new study by researchers from The University of Manchester.
 
Scientists find a near doubling of breast, ovarian and prostate cancer markers
27 March 2013
Scientists, including experts at The University of Manchester, have found a near doubling of the number of markers associated with breast, ovarian, and prostate cancer.
 
Teenage and young adult cancer deaths almost halved in last 30 years but success masks lack of access to clinical trials
25 March 2013
The number of teenagers and young adults* dying from cancer in Britain has fallen from around 580 per year in the mid-70s (1975-77) to around 300 today (2008-2010), according to a new Cancer Research UK report released today (Monday)**.
 
The Business of Beating Cancer
20 March 2013
The North West’s leading entrepreneurs have gathered to discuss how business can beat cancer.
 
Funding boost for research into pancreatic cancer
12 March 2013
The Pancreatic Cancer Research Fund has today (Tuesday 12 March) announced it is funding a £150,000 research project at Cancer Research UK’s Paterson Institute based at The University of Manchester.
 
Taking omega-3 fish oils could help to protect against skin cancer, according to researchers at The University of Manchester
26 February 2013
The team has just carried out the first clinical trial to examine the impact of the fish oils on the skin immunity of volunteers. Led by Professor Lesley Rhodes, Professor of Experimental Dermatology from the Photobiology Unit Dermatology Centre at the University, the study analysed the effect of taking omega-3 on 79 healthy volunteers.
 
Understanding why cells stick
15 February 2013
Research carried out by scientists at Georgia Institute of Technology and The University of Manchester has revealed new insights into how cells stick to each other and to other bodily structures, an essential function in the formation of tissue structures and organs.
 
Researchers in Manchester find genetic key to preventing spine tumours
15 February 2013
Genetic medicine experts from Manchester Biomedical Research Centre at Saint Mary’s Hospital and The University of Manchester have identified a new gene responsible for causing an inherited form of tumour, known as spinal meningioma.
 
Academics launch new clinically approved diet
14 February 2013
Two academics from The University of Manchester have come up with a new diet which they believe can help lower the risk of breast cancer.
 
Two drugs better than one to treat most deadly skin cancer
11 February 2013
Adding lung cancer drugs to targeted melanoma treatment could increase survival for certain patients, according to research published in Cancer Discovery today (Monday).
 
Breast cancer stem cells can be targeted to stop disease
04 February 2013
In a significant breakthrough scientists prove for the first time that breast cancer stem cells, the driving force of a tumour, can be targeted in cells from patients; an approach that could increase the chances of survival for women with aggressive breast cancers.
 
Yeast scientists reveal a novel player in the orchestra of the cell cycle
04 February 2013
Defective regulation of the cell cycle leading to uncontrolled growth is one of the hallmarks of cancer. In normal cells the cell cycle is a well-orchestrated series of events mediated by activation of key regulatory proteins that result in cell division (mitosis).
 

2012

Better approach to treating deadly melanoma identified by scientists
19 December 2012
Scientists at The University of Manchester have identified a protein that appears to hold the key to creating more effective drug treatments for melanoma, one of the deadliest cancers.
 
Scientists show that for yeast cell division it’s not what you do it’s where you do it
09 December 2012
A new paper published this month demonstrates that when it comes to activating cell division, location is everything.
 
Scientist awarded €150,000 prize for non-invasive cancer tests
28 November 2012
A scientist from The University of Manchester has been awarded a €150,000 (about £120,000) research prize for the development of scalpel-sparing tests for the diagnosis and management of cancer.
 
Cancer survivors dig for a future with "Breaking the Ground"
08 November 2012
Inspirational cancer survivors will take the first step in helping to build a new £28.5m research building for the Manchester Cancer Research Centre (MCRC) today (Thursday).
 
Multimillion pound funding boost for cancer research
01 November 2012
Cancer research in Manchester has been given a £12.8 million funding boost following a successful bid by The University of Manchester to the UK Research Partnership Investment Fund (UKRPIF).
 
Scientists unravel resistance to breast cancer treatment
01 November 2012
Scientists have identified a molecular ‘flag’ in women with breast cancer who do not respond or have become resistant to the hormone drug tamoxifen.
 
Prostate cancer prognosis hope
29 October 2012
Scientists have discovered a molecular ‘tell’ in laboratory experiments that could help doctors determine the severity of a patient’s prostate cancer.
 
Council chief to be next Chair of Manchester Health Partnership
29 October 2012
Manchester City Council’s Chief Executive Sir Howard Bernstein will be the next Chair of the Manchester Academic Health Science Centre (MAHSC).
 
Scientists harness immune system to prevent lymphoma relapse
18 October 2012
UK scientists hope that lymphoma patients could benefit from a new drug that triggers the cancer-fighting properties of the body’s own immune system, after highly promising early laboratory results.
 
Scientists develop improved imaging technique for brain tumours
27 August 2012
Scientists have developed a more accurate technique for imaging brain tumours that explains why different parts of the tumour have a different response to some anticancer drugs.
 
Scientists present new insights into the regulation of cell division
27 August 2012
A study of mechanisms that regulate cell division will better our understanding of the basic molecular processes that may lead to cancer.
 
PhD student receives Jack Fowler award
18 August 2012
Joana Senra, a final year PhD student in Ian Stratford’s group in the School of Pharmacy & Pharmaceutical Sciences has been awarded the Jack Fowler award for her work on targeting DNA damage response pathways to improve the outcome of radiotherapy.
 
Manchester scientists give new life to old samples
07 August 2012
Manchester scientists have found a new way of getting valuable information from tissue samples - even from those that have been stored for a long time and have started to reach the end of their shelf-life.
 
Scientists identify risk factor for relapse of childhood leukaemia
09 July 2012
Manchester scientists have identified a new risk factor associated with a high risk of relapse for childhood leukaemia. Developing drugs that target this factor may help to sensitise the leukaemia cells to chemotherapy and improve patient outcome after relapse.
 
DNA repair protein identified by scientists
06 July 2012
Scientists have found a novel DNA repair protein providing fresh insight into the processes of DNA damage that can lead to cancer.
 
Scientists identify a new mechanism of cell cycle regulation
11 June 2012
Scientists have discovered a new regulatory mechanism of cell cycle progression, giving insights into the mechanisms that may cause cancer.
 
Manchester scientists find new ways of making cancer cells more sensitive to radiotherapy
10 May 2012
Manchester scientists have synthesised new compounds that can make tumour cells more sensitive to radiotherapy and that could be used to improve cancer treatment.
 
Clinical Scientist receives national award
20 April 2012
One of The Christie's clinical scientists, Carl Rowbottom, has received the Chief Scientific Officer's Award for Leadership in the prestigious Advancing Healthcare Awards.
 
World's most advanced form of radiotherapy coming to Manchester
05 April 2012
The Department of Health has confirmed that up to £250m will be invested in building Proton Beam Therapy facilities at The Christie and University College London Hospitals NHS Foundation Trust.
 
Plans for new cancer research centre given green light
15 March 2012
Plans to build a state-of-the-art cancer research building for the Manchester Cancer Research Centre (MCRC) have been approved by Manchester City Council's planning committee.
 
Skin cancer drug trialled at The Christie now licensed in UK
14 March 2012
Zelboraf (vemurafenib), the first personalised treatment to extend life of patients with BRAF V600 mutation positive unresectable or metastatic melanoma to over a year, is now licensed for use in the UK following accelerated review by the EU Commission.
 
New Paterson Institute Director
02 March 2012
Professor Richard Marais, the new Director of the Paterson Institute for Cancer Research, took up his post on 1 February 2012.
 
NIHR Clinical Research Facility Funding for The Christie
02 March 2012
The Christie successfully obtained £4.5M funding from the National Institute for Health Research (NIHR) for its Phase I/II Cancer Trials Unit in recognition of the outstanding early phase research work already carried out.
 
New Clinical Director for The Christie Clinical Trials Unit
30 January 2012
Dr Andrew Wardley has been appointed director of the Clinical Trials Unit at The Christie.
 
National Advisory Group on Radiotherapy
30 January 2012
Dr Nick Slevin has been appointed as the Chair of a new national advisory group on radiotherapy.
 

Older

Professor Nic Jones appointed Chief Scientist of Cancer Research UK
17 December 2010
A world-leading cancer researcher has been appointed as the next Chief Scientist of Cancer Research UK.
 
Manchester cancer experts begin research on tissue samples
05 August 2009
Experts in Manchester begin research on a bank of high quality tissue from cancer patients across the county.
 
New way to kill cancer found using body's immune system
21 July 2009
Scientists have discovered a new way of killing cancer cells in a breakthrough that could eventually lead to new treatments for a range of different cancers.
 
Budding scientists focus on S pombe at the EMBO course
06 July 2009
A team of young scientists attended the European Molecular Biology Organisation (EMBO) practical course ‘Molecular genetics with the fission yeast Schizosaccharomyces pombe’ organised and held at The University of Manchester and the Paterson Institute for Cancer Research from 13-25 June 2009.
 
Cancer research in Manchester ranked top in the UK
18 December 2008
Cancer research in Manchester has been confirmed as world leading by a prestigious national assessment.
 
New funding fosters collaboration and partnership
05 September 2008
A new MCRC Collaborative Workshop Awards scheme has been established to encourage researchers and clinicians to develop strong partnerships across Greater Manchester.
 
Singapore scientists fly to Manchester to learn about cancer research
15 August 2008
Cancer researchers from Singapore are to travel across the globe to Manchester to gain unique world-class training at the Manchester Cancer Research Centre as part of a scheme which is a first for the UK. The pioneering partnership was announced at a press conference in Singapore today.
 
New Breakthrough Research Unit for Manchester
03 October 2007
A groundbreaking new breast cancer research unit in Manchester is being set up by the UK’s leading breast cancer charity, Breakthrough Breast Cancer.
 
Tissue Biobanking
02 October 2007
Basic and clinical research in many disease areas, and particularly in cancer, is beginning to rely much more heavily on the analysis of human tissue to improve our understanding of disease mechanisms, the beneficial and detrimental effects of therapy on patients, and which patients benefit most from treatments.
 
Boosting drug discovery
01 October 2007
The MCRC will amplify the search for new cancer drugs through the creation of a drug discovery unit.